0000825542-26-000024 | 10-Q | XBRL Viewer

Print Document

CONTINGENCIES (Details) $ in Millions	Mar. 28, 2026 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Accrual for environmental actions	$ 2.5

FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($) $ in Millions	6 Months Ended		12 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Sep. 30, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Expected credit losses		$ 1.9	$ 1.9
Convertible debt investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized cost basis of investment	$ 46.4	44.4	44.4
Unrealized gain (loss) on investment	(20.2)	$ (16.4)	$ 19.8
Expected credit losses	$ 1.9
Convertible debt investments \| Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt term	3 years 4 months 24 days

- Definition

Cost of the investment.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 55
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477439/946-210-55-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-6

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-6

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-12

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478795/946-210-50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 19
-Subparagraph (3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19

+ Details

DISCONTINUED OPERATIONS - Narrative (Details) $ / shares in Units, shares in Millions, $ in Millions		3 Months Ended		6 Months Ended
	Apr. 08, 2026 USD ($) member $ / shares shares	Mar. 28, 2026 USD ($)	Mar. 29, 2025 USD ($)	Mar. 28, 2026 USD ($)	Mar. 29, 2025 USD ($)	Sep. 30, 2025 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash and cash equivalents		$ 6.2	$ 8.7	$ 6.2	$ 8.7	$ 32.8
Cash provided by (used in) operating activities, discontinued operation				1.3	(17.3)
Subsequent Event
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of board members \| member	1
Discontinued Operations, Disposed of by Sale \| Subsequent Event
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal group, consideration (in shares) \| shares	213.0
Warrant term	5 years
Additional shares called by warrant (in shares) \| shares	80.0
Strike price (in dollars per share) \| $ / shares	$ 0.85
Manufacturing services commitment	$ 20.0
Discontinued operation, period of continuing involvement	2 years
Discontinued Operations, Disposed of by Sale \| Subsequent Event \| Hawthorne
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash and cash equivalents	$ 35.0
Discontinued Operations, Disposed of by Sale \| Subsequent Event \| Vireo Growth Inc.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Investment owned, percentage	14.00%
Discontinued Operations, Held-for-Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on measurement of held for sale assets		$ (29.6)	$ 0.0	$ (134.4)	$ 0.0

EARNINGS PER COMMON SHARE - Calculation of Earnings per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Mar. 28, 2026	Mar. 29, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income from continuing operations	$ 263.3	$ 220.7	$ 215.6	$ 154.7
Loss from discontinued operations, net of tax	(24.7)	(3.2)	(102.0)	(6.7)
Net income	$ 238.6	$ 217.5	$ 113.6	$ 148.0
Basic net income (loss) per common share:
Basic net income (loss) per common share, continuing operations (in dollars per share)	$ 4.53	$ 3.83	$ 3.72	$ 2.69
Basic net income (loss) per common share, discontinued operations (in dollars per share)	(0.42)	(0.05)	(1.76)	(0.12)
Basic income (loss) per common share (USD per share)	$ 4.11	$ 3.78	$ 1.96	$ 2.57
Weighted-average common shares outstanding during the period (in shares)	58,100,000	57,600,000	58,000,000.0	57,500,000
Diluted net income (loss) per common share:
Diluted net income (loss) per common share, continuing operations (in dollars per share)	$ 4.46	$ 3.78	$ 3.65	$ 2.64
Diluted net income (loss) per common share, discontinued operations (in dollars per share)	(0.42)	(0.06)	(1.72)	(0.11)
Diluted income (loss) per common share (USD per share)	$ 4.04	$ 3.72	$ 1.93	$ 2.53
Weighted-average common shares outstanding during the period (in shares)	58,100,000	57,600,000	58,000,000.0	57,500,000
Dilutive potential Common Shares (in shares)	1,000,000.0	800,000	1,000,000.0	1,100,000
Weighted-average common shares outstanding during the period plus dilutive potential common shares (in shares)	59,100,000	58,400,000	59,000,000.0	58,600,000
Options
Diluted net income (loss) per common share:
Number of anti-dilutive potential common shares excluded from the calculation (in shares)	600,000	600,000	800,000	400,000

EARNINGS PER COMMON SHARE (Tables)

6 Months Ended

Mar. 28, 2026

Earnings Per Share [Abstract]

Information to Calculate Basic and Diluted Earnings (Loss) Per Common Share

The following table presents information necessary to calculate basic and diluted net income (loss) per common share for the periods indicated:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

Net income from continuing operations	$	263.3	$	220.7	$	215.6	$	154.7


Loss from discontinued operations, net of tax	(24.7)		(3.2)		(102.0)		(6.7)
Net income	$	238.6	$	217.5	$	113.6	$	148.0
Basic net income (loss) per common share:
Continuing operations	$	4.53	$	3.83	$	3.72	$	2.69
Discontinued operations	(0.42)		(0.05)		(1.76)		(0.12)
Basic net income per common share	$	4.11	$	3.78	$	1.96	$	2.57

Weighted-average common shares outstanding during the period	58.1		57.6		58.0		57.5
Diluted net income (loss) per common share:
Continuing operations	$	4.46	$	3.78	$	3.65	$	2.64
Discontinued operations	(0.42)		(0.06)		(1.72)		(0.11)
Diluted net income per common share	$	4.04	$	3.72	$	1.93	$	2.53

Weighted-average common shares outstanding during the period	58.1		57.6		58.0		57.5
Dilutive potential common shares	1.0		0.8		1.0		1.1
Weighted-average common shares outstanding during the period plus dilutive potential common shares	59.1		58.4		59.0		58.6

Antidilutive stock options outstanding	0.6		0.6		0.8		0.4

EQUITY (Tables)

6 Months Ended

Mar. 28, 2026

Equity [Abstract]

Summary of Changes in Equity (Deficit)

The following tables provide a summary of the changes in equity (deficit) for each of the periods indicated:


	Common Shares and Capital in Excess of Stated Value		Retained Earnings		Treasury Shares		Accumulated Other Comprehensive Loss		Total Equity (Deficit)
Balance at September 30, 2025	$	351.6	$	294.7	$	(894.1)	$	(109.7)	$	(357.5)

Net income (loss)	—		(125.0)		—		—		(125.0)
Other comprehensive income (loss)	—		—		—		3.5		3.5
Share-based compensation	24.3		—		—		—		24.3
Dividends declared ($0.66 per share)	—		(38.5)		—		—		(38.5)
Treasury share purchases	—		—		(8.3)		—		(8.3)
Treasury share issuances	(29.0)		—		29.9		—		0.9



Balance at December 27, 2025	346.9		131.2		(872.5)		(106.2)		(500.6)

Net income (loss)	—		238.6		—		—		238.6
Other comprehensive income (loss)	—		—		—		1.2		1.2
Share-based compensation	13.8		—		—		—		13.8
Dividends declared ($0.66 per share)	—		(38.8)		—		—		(38.8)
Treasury share purchases	—		—		(3.3)		—		(3.3)
Treasury share issuances	(14.4)		—		17.0		—		2.6

Balance at March 28, 2026	$	346.3	$	331.0	$	(858.8)	$	(105.0)	$	(286.5)

The sum of the components may not equal due to rounding.


	Common Shares and Capital in Excess of Stated Value		Retained Earnings		Treasury Shares		Accumulated Other Comprehensive Loss		Total Equity (Deficit)
Balance at September 30, 2024	$	362.0	$	303.8	$	(949.1)	$	(107.3)	$	(390.6)

Net income (loss)	—		(69.5)		—		—		(69.5)
Other comprehensive income (loss)	—		—		—		2.5		2.5
Share-based compensation	31.4		—		—		—		31.4
Dividends declared ($0.66 per share)	—		(38.5)		—		—		(38.5)
Treasury share purchases	—		—		(15.6)		—		(15.6)
Treasury share issuances	(44.3)		—		45.1		—		0.8



Balance at December 28, 2024	349.1		195.8		(919.6)		(104.8)		(479.5)
Net income (loss)	—		217.5		—		—		217.5
Other comprehensive income (loss)	—		—		—		(4.0)		(4.0)
Share-based compensation	8.7		—		—		—		8.7
Dividends declared ($0.66 per share)	—		(39.6)		—		—		(39.6)
Treasury share purchases	—		—		(2.7)		—		(2.7)
Treasury share issuances	(14.5)		—		23.9		—		9.4

Balance at March 29, 2025	$	343.4	$	373.7	$	(898.4)	$	(108.8)	$	(290.1)

The sum of the components may not equal due to rounding.

Schedule of Accumulated Other Comprehensive Loss

Changes in accumulated other comprehensive loss (“AOCL”) by component were as follows for each of the periods indicated:


	Three Months Ended
	Foreign Currency Translation Adjustments		Net Unrealized Gain (Loss) On Derivative Instruments		Net Unrealized Gain (Loss) On Securities		Pension and Other Post-Retirement Benefit Adjustments		Accumulated Other Comprehensive Income (Loss)
Balance at December 27, 2025	$	(9.9)	$	(0.8)	$	(17.9)	$	(77.7)	$	(106.2)
Other comprehensive income (loss) before reclassifications	(2.0)		1.9		(0.4)		—		(0.5)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		0.7		—		3.1		3.8
Income tax benefit (expense)	—		(0.7)		—		(1.4)		(2.1)
Net current period other comprehensive income (loss)	(2.0)		1.9		(0.4)		1.7		1.2
Balance at March 28, 2026	$	(11.9)	$	1.1	$	(18.2)	$	(76.0)	$	(105.0)

Balance at December 28, 2024	$	(27.1)	$	8.9	$	(14.4)	$	(72.2)	$	(104.8)
Other comprehensive income (loss) before reclassifications	1.0		(1.9)		—		—		(0.9)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(3.0)		—		(2.7)		(5.7)
Income tax benefit (expense)	—		1.3		—		1.3		2.6
Net current period other comprehensive income (loss)	1.0		(3.6)		—		(1.4)		(4.0)
Balance at March 29, 2025	$	(26.1)	$	5.3	$	(14.4)	$	(73.6)	$	(108.8)

The sum of the components may not equal due to rounding.


	Six Months Ended
	Foreign Currency Translation Adjustments		Net Unrealized Gain (Loss) On Derivative Instruments		Net Unrealized Gain (Loss) On Securities		Pension and Other Post-Retirement Benefit Adjustments		Accumulated Other Comprehensive Income (Loss)
Balance at September 30, 2025	$	(12.2)	$	0.3	$	(17.9)	$	(79.9)	$	(109.7)
Other comprehensive income (loss) before reclassifications	0.3		2.9		(0.4)		—		2.8
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(2.0)		—		7.4		5.4
Income tax benefit (expense)	—		(0.2)		—		(3.5)		(3.7)
Net current period other comprehensive income (loss)	0.3		0.7		(0.4)		3.9		4.5
Balance at March 28, 2026	$	(11.9)	$	1.1	$	(18.2)	$	(76.0)	$	(105.0)

Balance at September 30, 2024	$	(21.3)	$	4.9	$	(14.4)	$	(76.5)	$	(107.3)
Other comprehensive income (loss) before reclassifications	(4.9)		5.8		—		—		0.9
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(5.1)		—		5.4		0.3
Income tax benefit (expense)	—		(0.2)		—		(2.5)		(2.7)
Net current period other comprehensive income (loss)	(4.9)		0.5		—		2.9		(1.5)
Balance at March 29, 2025	$	(26.1)	$	5.3	$	(14.4)	$	(73.6)	$	(108.8)

The sum of the components may not equal due to rounding.

Schedule of Share-Based Compensation

Total compensation cost and the related income tax benefit associated with share-based awards included within net income from continuing operations was as follows for each of the periods indicated:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

Share-based compensation	$	18.5	$	22.0	$	25.9	$	38.4
Related tax benefit recognized	1.9		4.1		3.3		6.6

Schedule of Stock Option Activity

Stock option activity was as follows:


	No. of Options	Wtd. Avg. Exercise Price		Wtd. Avg. Remaining Life	Aggregate Intrinsic Value
Awards outstanding at September 30, 2025	2,527,668	$	66.43	7.3 years
Granted	469,884	64.22
Exercised	(42,729)	59.45
Forfeited	(168,247)	64.44
Awards outstanding at March 28, 2026	2,786,576	66.28		7.7 years	$	13.9
Exercisable	740,432	84.28		6.0 years	5.5

Summary of Assumptions Used in the Estimation of Fair Value for Awards

The weighted average assumptions used in the estimation of fair value for awards granted during the six months ended March 28, 2026 are as follows:



Expected volatility	38.9	%
Risk-free interest rate	3.9	%
Expected dividend yield	3.6	%
Expected life	6.1 years

Schedule of Restricted Share-based Award Activity

Restricted share-based award activity (including restricted stock units and deferred stock units) was as follows:


	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit
Awards outstanding at September 30, 2025	478,924	$	61.28
Granted	417,007	58.84
Vested	(457,117)	62.38
Forfeited	(3,027)	60.49
Awards outstanding at March 28, 2026	435,787	57.84

Schedule of Performance-based Award Activity

Performance-based award activity was as follows (based on target award amounts):


	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit
Awards outstanding at September 30, 2025	444,748	$	75.38
Granted	220,519	64.22
Vested (a)	(90,679)	79.13
Forfeited	(2,030)	62.64
Awards outstanding at March 28, 2026	572,558	70.17

(a) Vested at a weighted average of 100% of the target performance share units granted.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025
Accounting Policies [Abstract]
Interest paid	$ 58.0	$ 68.1
Income taxes paid (refunded), net	$ 4.2	$ (4.2)

LEASES (Tables)

6 Months Ended

Mar. 28, 2026

Leases [Abstract]

Weighted-Average Remaining Lease Term and Discount Rate and Supplemental Balance Sheet Information Schedule

Supplemental balance sheet information related to the Company’s leases was as follows:


	Balance Sheet Location	March 28, 2026		March 29, 2025		September 30, 2025

Operating leases:
Right-of-use assets	Other assets	$	284.4	$	252.5	$	243.9

Current lease liabilities	Other current liabilities	60.9		69.7		67.5
Non-current lease liabilities	Other liabilities	256.9		202.8		192.6
Total operating lease liabilities		$	317.8	$	272.5	$	260.1

Finance leases:
Right-of-use assets	Property, plant and equipment, net	$	10.7	$	12.9	$	11.7

Current lease liabilities	Current portion of debt	2.0		2.1		2.0
Non-current lease liabilities	Long-term debt	11.5		13.5		12.5
Total finance lease liabilities		$	13.5	$	15.6	$	14.5

Weighted-average remaining lease term and discount rate for the Company’s leases were as follows:


	March 28, 2026		March 29, 2025		September 30, 2025
Weighted-average remaining lease term (in years):
Operating leases	7.7		5.3		5.2
Finance leases	7.5		8.1		7.8

Weighted-average discount rate:
Operating leases	7.2	%	6.7	%	7.0	%
Finance leases	4.6	%	4.6	%	4.6	%

Lease Cost Components and Supplemental Cash Flow Information and Non-Cash Activity For Company's Leases Schedules

Components of lease cost were as follows:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

Operating lease cost (a)	$	22.3	$	20.1	$	43.8	$	40.1
Variable lease cost	6.3		6.3		10.9		10.9


Finance lease cost
Amortization of right-of-use assets	0.6		0.6		1.1		1.3
Interest on lease liabilities	0.1		0.2		0.3		0.4
Total finance lease cost	$	0.7	$	0.8	$	1.4	$	1.7

(a)Operating lease cost includes amortization of right-of-use assets of $16.9 and $33.3 for the three and six months ended March 28, 2026, respectively, and $16.0 and $32.0 for the three and six months ended March 29, 2025, respectively. Short-term lease expense is excluded from operating lease cost and is not material.

Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows:


	Six Months Ended
		March 28, 2026		March 29, 2025
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases, net		$	43.4	$	39.8
Operating cash flows from finance leases		0.3		0.4
Financing cash flows from finance leases		1.0		1.2

Right-of-use assets obtained in exchange for lease obligations:
Operating leases		$	90.7	$	34.3
Finance leases		—		0.4

Maturities of Operating Lease Liabilities by Fiscal Year Schedule

Maturities of lease liabilities by fiscal year for the Company’s leases as of March 28, 2026 were as follows:


Year	Operating Leases		Finance Leases
2026 (remainder of the year)	$	44.4	$	1.3
2027	70.8		2.5
2028	61.8		2.1
2029	49.1		1.7
2030	36.8		1.7
Thereafter	159.4		7.0
Total lease payments	422.3		16.3
Less: Imputed interest	(104.5)		(2.8)
Total lease liabilities	$	317.8	$	13.5

Maturities of Finance Lease Liabilities by Fiscal Year Schedule

Maturities of lease liabilities by fiscal year for the Company’s leases as of March 28, 2026 were as follows:


Year	Operating Leases		Finance Leases
2026 (remainder of the year)	$	44.4	$	1.3
2027	70.8		2.5
2028	61.8		2.1
2029	49.1		1.7
2030	36.8		1.7
Thereafter	159.4		7.0
Total lease payments	422.3		16.3
Less: Imputed interest	(104.5)		(2.8)
Total lease liabilities	$	317.8	$	13.5

SEGMENT INFORMATION - Net Sales, Profit (Loss), and Assets by Segment (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Mar. 28, 2026	Mar. 29, 2025
Segment Reporting Information [Line Items]
Net sales	$ 1,459.5	$ 1,389.7	$ 1,814.0	$ 1,756.3
Impairment, restructuring and other	(2.2)	(10.4)	(3.9)	(27.0)
Equity in loss of unconsolidated affiliates	(4.5)	(5.9)	(17.6)	(15.8)
Interest expense	(31.3)	(36.6)	(58.5)	(70.5)
Other non-operating expense, net	(1.1)	(1.2)	(2.3)	(2.5)
Continuing Operations
Segment Reporting Information [Line Items]
Segment Profit	364.9	306.0	301.6	215.1
Intangible asset amortization	(0.7)	(0.7)	(1.3)	(1.4)
Impairment, restructuring and other	(2.2)	(15.7)	(5.2)	(33.7)
Equity in loss of unconsolidated affiliates	(4.5)	(5.9)	(17.6)	(15.8)
Interest expense	(31.3)	(36.6)	(58.5)	(70.5)
Other non-operating expense, net	(1.1)	(1.2)	(2.3)	(2.5)
Corporate \| Continuing Operations
Segment Reporting Information [Line Items]
Segment Profit	(44.7)	(35.0)	(70.0)	(69.0)
U.S. Consumer reportable segment
Segment Reporting Information [Line Items]
Net sales	1,377.0	1,311.5	1,705.5	1,652.4
U.S. Consumer reportable segment \| Operating Segments \| Continuing Operations
Segment Reporting Information [Line Items]
Segment Profit	437.3	392.1	446.3	402.0
U.S. Consumer reportable segment \| Operating Segments
Segment Reporting Information [Line Items]
Adjusted cost of sales	786.7	781.4	1,028.2	1,034.6
Adjusted selling, general and administrative	145.9	133.2	220.6	206.5
Other segment items	7.1	4.8	10.4	9.3
Other non-reportable operating segment
Segment Reporting Information [Line Items]
Net sales	82.5	78.2	108.5	103.9
Other non-reportable operating segment \| Operating Segments \| Continuing Operations
Segment Reporting Information [Line Items]
Segment Profit	$ 12.1	$ 9.0	$ 10.2	$ 6.0

FAIR VALUE MEASUREMENTS - Summary of Fair Value of Assets and Liabilities (Details) - USD ($) $ in Millions	Mar. 28, 2026	Sep. 30, 2025	Mar. 29, 2025	Aug. 13, 2021	Mar. 17, 2021	Oct. 22, 2019	Dec. 15, 2016
Senior notes \| 4.000% Senior Notes
Liabilities
Interest rate of debt (percentage)	4.00%	4.00%	4.00%		4.00%
Senior notes \| 4.375% Senior Notes
Liabilities
Interest rate of debt (percentage)	4.375%	4.375%	4.375%	4.375%
Senior notes \| 4.500% Senior Notes
Liabilities
Interest rate of debt (percentage)	4.50%	4.50%	4.50%			4.50%
Senior notes \| 5.250% Senior Notes
Liabilities
Interest rate of debt (percentage)	5.25%	5.25%	5.25%				5.25%
Carrying Amount \| Fair value, inputs, level 1 \| Fair Value, Measurements, Recurring
Assets
Cash equivalents	$ 0.0	$ 25.3	$ 5.0
Carrying Amount \| Fair value, inputs, level 1 \| Fair Value, Measurements, Recurring \| Investment securities in non-qualified retirement plan assets
Assets
Other	30.2	32.6	30.4
Carrying Amount \| Fair value, inputs, level 3 \| Fair Value, Measurements, Recurring \| Convertible debt investments
Assets
Other	26.2	24.6	28.1
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Credit facilities \| Revolving loans
Liabilities
Debt instruments	251.2	0.0	345.0
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Credit facilities \| Term loans
Liabilities
Debt instruments	493.8	500.0	600.0
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 4.000% Senior Notes
Liabilities
Debt instruments	500.0	500.0	500.0
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 4.375% Senior Notes
Liabilities
Debt instruments	400.0	400.0	400.0
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 4.500% Senior Notes
Liabilities
Debt instruments	450.0	450.0	450.0
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 5.250% Senior Notes
Liabilities
Debt instruments	250.0	250.0	250.0
Carrying Amount \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Other debt
Liabilities
Debt instruments	2.3	5.2	2.5
Estimated Fair Value \| Fair value, inputs, level 1 \| Fair Value, Measurements, Recurring
Assets
Cash equivalents	0.0	25.3	5.0
Estimated Fair Value \| Fair value, inputs, level 1 \| Fair Value, Measurements, Recurring \| Investment securities in non-qualified retirement plan assets
Assets
Other	30.2	32.6	30.4
Estimated Fair Value \| Fair value, inputs, level 3 \| Fair Value, Measurements, Recurring \| Convertible debt investments
Assets
Other	26.2	24.6	28.1
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Credit facilities \| Revolving loans
Liabilities
Debt instruments	251.2	0.0	345.0
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Credit facilities \| Term loans
Liabilities
Debt instruments	493.8	500.0	600.0
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 4.000% Senior Notes
Liabilities
Debt instruments	455.6	459.4	440.0
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 4.375% Senior Notes
Liabilities
Debt instruments	366.5	367.0	353.0
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 4.500% Senior Notes
Liabilities
Debt instruments	435.4	437.1	420.8
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Senior notes \| 5.250% Senior Notes
Liabilities
Debt instruments	249.1	249.4	247.8
Estimated Fair Value \| Fair value, inputs, level 2 \| Fair Value, Measurements, Recurring \| Other debt
Liabilities
Debt instruments	$ 2.3	$ 5.2	$ 2.5

IMPAIRMENT, RESTRUCTURING AND OTHER - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 29, 2025	Dec. 28, 2024	Mar. 28, 2026	Mar. 29, 2025
Restructuring Cost and Reserve [Line Items]
Restructuring reserve, long-term			$ 1.1
Loss on exchange of convertible debt		$ 7.0
Operating expenses
Restructuring Cost and Reserve [Line Items]
Loss on exchange of convertible debt	$ 0.0		$ 0.0	$ 7.0
U.S. Consumer reportable segment \| Cost of sales—impairment, restructuring and other
Restructuring Cost and Reserve [Line Items]
Other Restructuring Costs	2.3			3.7
U.S. Consumer reportable segment \| Cost of sales—impairment, restructuring and other \| Employee and Executive Severance
Restructuring Cost and Reserve [Line Items]
Severance costs	3.0			3.0
U.S. Consumer reportable segment \| Restructuring, Settlement And Impairment Provisions
Restructuring Cost and Reserve [Line Items]
Severance costs	3.3			3.3
Corporate Segment \| Restructuring, Settlement And Impairment Provisions
Restructuring Cost and Reserve [Line Items]
Severance costs	$ 2.1			$ 11.6

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

6 Months Ended

Mar. 28, 2026

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

NOTE 12. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. To manage a portion of the volatility related to these exposures, the Company enters into various financial transactions. The utilization of these financial transactions is governed by policies covering acceptable counterparty exposure, instrument types and other hedging practices. The Company does not hold or issue derivative financial instruments for speculative trading purposes.

The fair values and amount of gain (loss) recognized in earnings and AOCL associated with derivative instruments did not have a material impact on the Company’s condensed consolidated financial statements for the three and six months ended March 28, 2026 and March 29, 2025.

Exchange Rate Risk Management

The Company uses currency forward contracts to manage the exchange rate risk associated with intercompany loans and certain other balances denominated in foreign currencies. Currency forward contracts are valued using observable forward rates in commonly quoted intervals for the full term of the contracts. The notional amount of outstanding currency forward contracts was $161.4, $157.3 and $100.4 at March 28, 2026, March 29, 2025 and September 30, 2025, respectively. Contracts outstanding at March 28, 2026 will mature over the next fiscal quarter.

Interest Rate Risk Management

The Company enters into interest rate swap agreements as a means to hedge its variable interest rate risk on debt instruments. Net amounts to be received or paid under the swap agreements are reflected as adjustments to interest expense. The Company has outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. Interest rate swap agreements are valued based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date. Swap agreements that were hedging interest payments as of March 28, 2026, March 29, 2025 and September 30, 2025 had a maximum total U.S. dollar equivalent notional amount of $450.0. Refer to “NOTE 7. DEBT” for the terms of the swap agreements outstanding at March 28, 2026. Gains and losses included in the AOCL balance at March 28, 2026 related to interest rate swap agreements that are expected to be reclassified to earnings during the next twelve months are not material.

Commodity Price Risk Management

The Company enters into hedging arrangements designed to fix the price of a portion of its projected future urea and diesel requirements. Commodity contracts are valued using observable commodity exchange prices in active markets. Gains and losses included in the AOCL balance at March 28, 2026 related to commodity hedges that are expected to be reclassified to earnings during the next twelve months are not material.

The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:

Commodity

March 28,
2026

March 29,
2025

September 30,
2025

Urea

—

6,000 tons

49,500 tons

Diesel

1,596,000 gallons

1,428,000 gallons

2,478,000 gallons

Heating Oil

1,218,000 gallons

798,000 gallons

1,050,000 gallons

- Definition

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 182
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-182

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 185
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-185

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 184
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-184

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 181
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-181

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)(5)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4H
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4H

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4H
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4H

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 15
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480960/815-15-50-3

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 183
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-183

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4I
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4I

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4F
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4F

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/815/tableOfContent

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-5C

+ Details

Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Mar. 28, 2026	Mar. 29, 2025
Income Statement [Abstract]
Net sales	$ 1,459.5	$ 1,389.7	$ 1,814.0	$ 1,756.3
Cost of sales	849.0	842.3	1,113.5	1,119.0
Cost of sales—impairment, restructuring and other	0.0	5.3	1.3	6.7
Gross margin	610.5	542.1	699.2	630.6
Operating expenses:
Selling, general and administrative	199.2	177.8	305.1	291.3
Impairment, restructuring and other	2.2	10.4	3.9	27.0
Other expense, net	7.3	4.2	10.2	8.4
Income from operations	401.8	349.7	380.0	303.9
Equity in loss of unconsolidated affiliates	4.5	5.9	17.6	15.8
Interest expense	31.3	36.6	58.5	70.5
Other non-operating expense, net	1.1	1.2	2.3	2.5
Income from continuing operations before income taxes	364.9	306.0	301.6	215.1
Income tax expense from continuing operations	101.6	85.3	86.0	60.4
Net income from continuing operations	263.3	220.7	215.6	154.7
Loss from discontinued operations, net of tax	(24.7)	(3.2)	(102.0)	(6.7)
Net income	$ 238.6	$ 217.5	$ 113.6	$ 148.0
Basic net income (loss) per common share:
Income (loss) from continuing operations (USD per share)	$ 4.53	$ 3.83	$ 3.72	$ 2.69
Income (loss) from discontinued operations (USD per share)	(0.42)	(0.05)	(1.76)	(0.12)
Basic income (loss) per common share (USD per share)	4.11	3.78	1.96	2.57
Diluted net income (loss) per common share:
Income (loss) from continuing operations (USD per share)	4.46	3.78	3.65	2.64
Income (loss) from discontinued operations (USD per share)	(0.42)	(0.06)	(1.72)	(0.11)
Diluted income (loss) per common share (USD per share)	$ 4.04	$ 3.72	$ 1.93	$ 2.53
Weighted-average common shares outstanding during the period (in shares)	58.1	57.6	58.0	57.5
Weighted-average common shares outstanding during the period plus dilutive potential common shares (in shares)	59.1	58.4	59.0	58.6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Mar. 28, 2026

Accounting Policies [Abstract]

Schedule of Supplemental Cash Flow Information

Supplemental cash flow information was as follows:


	Six Months Ended
	March 28, 2026		March 29, 2025

Interest paid	$	58.0	$	68.1

Income taxes paid (refunded), net	4.2		(4.2)

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 28, 2026	Sep. 30, 2025	Mar. 29, 2025
Current assets:
Cash and cash equivalents	$ 6.2	$ 32.8	$ 8.7
Accounts receivable, less allowances of $19.8, $18.1 and $10.5, respectively	766.7	160.8	767.8
Inventories	696.0	542.7	709.6
Current assets held for sale	28.5	84.8	118.0
Prepaid and other current assets	124.5	119.2	124.5
Total current assets	1,621.9	940.3	1,728.6
Investment in unconsolidated affiliates	36.0	53.6	40.6
Property, plant and equipment, net of accumulated depreciation of $850.6, $800.4 and $819.7, respectively	627.4	607.6	571.3
Goodwill	243.9	243.9	243.9
Intangible assets, net	350.9	352.0	353.0
Noncurrent assets held for sale	0.0	91.9	103.7
Other assets	531.9	452.7	495.6
Total assets	3,412.0	2,742.0	3,536.7
Current liabilities:
Current portion of debt	279.4	57.2	54.6
Accounts payable	385.8	221.4	382.6
Current liabilities held for sale	29.1	24.3	36.7
Other current liabilities	581.3	436.8	538.6
Total current liabilities	1,275.6	739.7	1,012.5
Long-term debt	2,068.4	2,049.2	2,493.2
Noncurrent liabilities held for sale	0.0	9.6	3.8
Other liabilities	354.5	301.0	317.3
Total liabilities	3,698.5	3,099.5	3,826.8
Commitments and contingencies
Equity (deficit):
Common Stock, Shares Issued, Not Disclosed	true	true	true
Number Of Authorized Shares Not Disclosed	true	true	true
Common shares and capital in excess of $0.01 stated value per share; shares outstanding of 58.2, 57.7 and 57.8, respectively	$ 346.3	$ 351.6	$ 343.4
Retained earnings	331.0	294.7	373.7
Treasury shares, at cost; 10.0, 10.5 and 10.4 shares, respectively	(858.8)	(894.1)	(898.4)
Accumulated other comprehensive loss	(105.0)	(109.7)	(108.8)
Total equity (deficit)	(286.5)	(357.5)	(290.1)
Total liabilities and equity (deficit)	$ 3,412.0	$ 2,742.0	$ 3,536.7

INVENTORIES

6 Months Ended

Mar. 28, 2026

Inventory Disclosure [Abstract]

INVENTORIES

NOTE 5. INVENTORIES

Inventories consisted of the following for each of the periods presented:


	March 28, 2026		March 29, 2025		September 30, 2025

Finished goods	$	430.8	$	408.3	$	246.3
Raw materials	193.1		227.3		217.6
Work-in-process	72.1		74.0		78.8
Total	$	696.0	$	709.6	$	542.7

EQUITY

6 Months Ended

Mar. 28, 2026

Equity [Abstract]

EQUITY (DEFICIT)

NOTE 8. EQUITY (DEFICIT)

The following tables provide a summary of the changes in equity (deficit) for each of the periods indicated:


	Common Shares and Capital in Excess of Stated Value		Retained Earnings		Treasury Shares		Accumulated Other Comprehensive Loss		Total Equity (Deficit)
Balance at September 30, 2025	$	351.6	$	294.7	$	(894.1)	$	(109.7)	$	(357.5)

Net income (loss)	—		(125.0)		—		—		(125.0)
Other comprehensive income (loss)	—		—		—		3.5		3.5
Share-based compensation	24.3		—		—		—		24.3
Dividends declared ($0.66 per share)	—		(38.5)		—		—		(38.5)
Treasury share purchases	—		—		(8.3)		—		(8.3)
Treasury share issuances	(29.0)		—		29.9		—		0.9



Balance at December 27, 2025	346.9		131.2		(872.5)		(106.2)		(500.6)

Net income (loss)	—		238.6		—		—		238.6
Other comprehensive income (loss)	—		—		—		1.2		1.2
Share-based compensation	13.8		—		—		—		13.8
Dividends declared ($0.66 per share)	—		(38.8)		—		—		(38.8)
Treasury share purchases	—		—		(3.3)		—		(3.3)
Treasury share issuances	(14.4)		—		17.0		—		2.6

Balance at March 28, 2026	$	346.3	$	331.0	$	(858.8)	$	(105.0)	$	(286.5)

The sum of the components may not equal due to rounding.


	Common Shares and Capital in Excess of Stated Value		Retained Earnings		Treasury Shares		Accumulated Other Comprehensive Loss		Total Equity (Deficit)
Balance at September 30, 2024	$	362.0	$	303.8	$	(949.1)	$	(107.3)	$	(390.6)

Net income (loss)	—		(69.5)		—		—		(69.5)
Other comprehensive income (loss)	—		—		—		2.5		2.5
Share-based compensation	31.4		—		—		—		31.4
Dividends declared ($0.66 per share)	—		(38.5)		—		—		(38.5)
Treasury share purchases	—		—		(15.6)		—		(15.6)
Treasury share issuances	(44.3)		—		45.1		—		0.8



Balance at December 28, 2024	349.1		195.8		(919.6)		(104.8)		(479.5)
Net income (loss)	—		217.5		—		—		217.5
Other comprehensive income (loss)	—		—		—		(4.0)		(4.0)
Share-based compensation	8.7		—		—		—		8.7
Dividends declared ($0.66 per share)	—		(39.6)		—		—		(39.6)
Treasury share purchases	—		—		(2.7)		—		(2.7)
Treasury share issuances	(14.5)		—		23.9		—		9.4

Balance at March 29, 2025	$	343.4	$	373.7	$	(898.4)	$	(108.8)	$	(290.1)

The sum of the components may not equal due to rounding.

Accumulated Other Comprehensive Loss

Changes in accumulated other comprehensive loss (“AOCL”) by component were as follows for each of the periods indicated:


	Three Months Ended
	Foreign Currency Translation Adjustments		Net Unrealized Gain (Loss) On Derivative Instruments		Net Unrealized Gain (Loss) On Securities		Pension and Other Post-Retirement Benefit Adjustments		Accumulated Other Comprehensive Income (Loss)
Balance at December 27, 2025	$	(9.9)	$	(0.8)	$	(17.9)	$	(77.7)	$	(106.2)
Other comprehensive income (loss) before reclassifications	(2.0)		1.9		(0.4)		—		(0.5)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		0.7		—		3.1		3.8
Income tax benefit (expense)	—		(0.7)		—		(1.4)		(2.1)
Net current period other comprehensive income (loss)	(2.0)		1.9		(0.4)		1.7		1.2
Balance at March 28, 2026	$	(11.9)	$	1.1	$	(18.2)	$	(76.0)	$	(105.0)

Balance at December 28, 2024	$	(27.1)	$	8.9	$	(14.4)	$	(72.2)	$	(104.8)
Other comprehensive income (loss) before reclassifications	1.0		(1.9)		—		—		(0.9)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(3.0)		—		(2.7)		(5.7)
Income tax benefit (expense)	—		1.3		—		1.3		2.6
Net current period other comprehensive income (loss)	1.0		(3.6)		—		(1.4)		(4.0)
Balance at March 29, 2025	$	(26.1)	$	5.3	$	(14.4)	$	(73.6)	$	(108.8)

The sum of the components may not equal due to rounding.


	Six Months Ended
	Foreign Currency Translation Adjustments		Net Unrealized Gain (Loss) On Derivative Instruments		Net Unrealized Gain (Loss) On Securities		Pension and Other Post-Retirement Benefit Adjustments		Accumulated Other Comprehensive Income (Loss)
Balance at September 30, 2025	$	(12.2)	$	0.3	$	(17.9)	$	(79.9)	$	(109.7)
Other comprehensive income (loss) before reclassifications	0.3		2.9		(0.4)		—		2.8
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(2.0)		—		7.4		5.4
Income tax benefit (expense)	—		(0.2)		—		(3.5)		(3.7)
Net current period other comprehensive income (loss)	0.3		0.7		(0.4)		3.9		4.5
Balance at March 28, 2026	$	(11.9)	$	1.1	$	(18.2)	$	(76.0)	$	(105.0)

Balance at September 30, 2024	$	(21.3)	$	4.9	$	(14.4)	$	(76.5)	$	(107.3)
Other comprehensive income (loss) before reclassifications	(4.9)		5.8		—		—		0.9
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(5.1)		—		5.4		0.3
Income tax benefit (expense)	—		(0.2)		—		(2.5)		(2.7)
Net current period other comprehensive income (loss)	(4.9)		0.5		—		2.9		(1.5)
Balance at March 29, 2025	$	(26.1)	$	5.3	$	(14.4)	$	(73.6)	$	(108.8)

The sum of the components may not equal due to rounding.

Share Repurchases

On December 19, 2025, the Company’s Board of Directors authorized a share repurchase program, with no expiration date, for the repurchase of up to $500.0 of Common Shares. There have been no share repurchases under this authorization as of March 28, 2026.

Share-Based Awards

On January 26, 2026, the shareholders of Scotts Miracle-Gro approved an amendment and restatement of The Scotts Miracle-Gro Company Long-Term Incentive Plan which, among other changes, increased the maximum number of Common Shares available for grant to participants under the Plan by 2.75 million Common Shares.

Total compensation cost and the related income tax benefit associated with share-based awards included within net income from continuing operations was as follows for each of the periods indicated:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

Share-based compensation	$	18.5	$	22.0	$	25.9	$	38.4
Related tax benefit recognized	1.9		4.1		3.3		6.6

Stock Options

Stock option activity was as follows:


	No. of Options	Wtd. Avg. Exercise Price		Wtd. Avg. Remaining Life	Aggregate Intrinsic Value
Awards outstanding at September 30, 2025	2,527,668	$	66.43	7.3 years
Granted	469,884	64.22
Exercised	(42,729)	59.45
Forfeited	(168,247)	64.44
Awards outstanding at March 28, 2026	2,786,576	66.28		7.7 years	$	13.9
Exercisable	740,432	84.28		6.0 years	5.5

The weighted-average fair value per share of each option granted during the six months ended March 28, 2026 and March 29, 2025 was $19.33 and $22.20, respectively. The total intrinsic value of options exercised during the six months ended March 28, 2026 and March 29, 2025 was not material. As of March 28, 2026, there was $8.5 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options that is expected to be recognized over a weighted-average period of 1.9 years. Cash received from the exercise of stock options, including amounts received from employee purchases under the employee stock purchase plan, was $3.3 and $10.0 for the six months ended March 28, 2026 and March 29, 2025, respectively.

The weighted average assumptions used in the estimation of fair value for awards granted during the six months ended March 28, 2026 are as follows:



Expected volatility	38.9	%
Risk-free interest rate	3.9	%
Expected dividend yield	3.6	%
Expected life	6.1 years

Restricted share-based awards

Restricted share-based award activity (including restricted stock units and deferred stock units) was as follows:


	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit
Awards outstanding at September 30, 2025	478,924	$	61.28
Granted	417,007	58.84
Vested	(457,117)	62.38
Forfeited	(3,027)	60.49
Awards outstanding at March 28, 2026	435,787	57.84

The weighted-average grant-date fair value of restricted share-based awards granted during the six months ended March 28, 2026 and March 29, 2025 was $58.84 and $74.21 per share, respectively. As of March 28, 2026, there was $5.4 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share-based awards that is expected to be recognized over a weighted-average period of 1.1 years. The total fair value of restricted share-based awards vested during the six months or fiscal 2026, the Company is granting short-term equity incentive compensation awards to certain associates in the form of restricted share-based award units in lieu of cash-based annual incentive awards. The program is structured so the fiscal 2026 incentive grant, if any, will be made on or near the incentive payout date, subject to certain performance conditions and a service requirement. The number of restricted share-based award units ultimately issued to participating associates will be based on each associate’s incentive payout amount converted into a variable number of restricted share-based award units based on the fair value of the Common Shares on the grant date. The awards are classified as liability awards and, as of March 28, 2026, the Company had accrued $8.8 in the “Other current liabilities” line in the Condensed Consolidated Balance Sheets associated with these awards. As of March 28, 2026, there was $10.4 of total unrecognized pre-tax compensation cost related to these nonvested restricted share-based award units that is expected to be recognized over the remainder of fiscal 2026. The units associated with these awards are excluded from the table above.

Performance-based awards

Performance-based award activity was as follows (based on target award amounts):


	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit
Awards outstanding at September 30, 2025	444,748	$	75.38
Granted	220,519	64.22
Vested (a)	(90,679)	79.13
Forfeited	(2,030)	62.64
Awards outstanding at March 28, 2026	572,558	70.17

(a) Vested at a weighted average of 100% of the target performance share units granted.

The weighted-average grant-date fair value of performance-based award units granted during the six months ended March 28, 2026 and March 29, 2025 was $64.22 and $72.01 per share, respectively. As of March 28, 2026, there was $10.6 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance-based award units that is expected to be recognized over a weighted-average period of 2.2 years. The total fair value of performance-based award units vested during the six months ended March 28, 2026 and March 29, 2025 was $5.7 and $0.0, respectively.

- Definition

The entire disclosure for equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478448/946-505-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-6

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-16

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

+ Details

INVESTMENT IN UNCONSOLIDATED AFFILIATES (Details) shares in Millions	3 Months Ended			6 Months Ended
	Mar. 28, 2026 USD ($) member	Mar. 29, 2025 USD ($)	Dec. 28, 2024 USD ($)	Mar. 28, 2026 USD ($) member	Mar. 29, 2025 USD ($)	Apr. 30, 2026	Apr. 08, 2026 member	Dec. 27, 2025 USD ($)	Sep. 30, 2025 USD ($)	Jul. 18, 2025 shares	Dec. 31, 2020
Investments in and Advances to Affiliates, Activity [Line Items]
Equity in loss of unconsolidated affiliates	$ 4,500,000	$ 5,900,000		$ 17,600,000	$ 15,800,000
Loss on exchange of convertible debt			$ 7,000,000.0
Investment in unconsolidated affiliates	36,000,000.0	40,600,000		36,000,000.0	40,600,000				$ 53,600,000
Subsequent Event
Investments in and Advances to Affiliates, Activity [Line Items]
Number of board members \| member							1
Share exchange ratio						0.0705359
Bonnie Plants
Investments in and Advances to Affiliates, Activity [Line Items]
Equity ownership percentage											50.00%
Equity in loss of unconsolidated affiliates	$ 4,500,000	$ 5,900,000		$ 15,100,000	$ 15,800,000
Fluent
Investments in and Advances to Affiliates, Activity [Line Items]
Common shares acquired (in shares) \| shares										153.1
Equity ownership percentage										0.25
Number of board members \| member	2			2
Investment in unconsolidated affiliates								$ 0

LEASES - Maturities of Lease Liabilities by Fiscal Year Schedule (Details) - USD ($) $ in Millions	Mar. 28, 2026	Sep. 30, 2025	Mar. 29, 2025
Operating Leases
2026 (remainder of the year)	$ 44.4
2027	70.8
2028	61.8
2029	49.1
2030	36.8
Thereafter	159.4
Total lease payments	422.3
Less: Imputed interest	(104.5)
Total lease liabilities	317.8	$ 260.1	$ 272.5
Finance Leases
2026 (remainder of the year)	1.3
2027	2.5
2028	2.1
2029	1.7
2030	1.7
Thereafter	7.0
Total lease payments	16.3
Less: Imputed interest	(2.8)
Total lease liabilities	$ 13.5	$ 14.5	$ 15.6

SEGMENT INFORMATION (Tables)

6 Months Ended

Mar. 28, 2026

Segment Reporting [Abstract]

Summary of Segment Financial Information

The following table presents net sales by segment and a reconciliation to the Company’s consolidated net sales for the periods indicated:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025


U.S. Consumer reportable segment	$	1,377.0	$	1,311.5	$	1,705.5	$	1,652.4
Other non-reportable operating segment	82.5		78.2		108.5		103.9
Consolidated	$	1,459.5	$	1,389.7	$	1,814.0	$	1,756.3

The following table presents Segment Profit (Loss), including the significant segment expenses provided to the CODM, and a reconciliation to income from continuing operations before income taxes for the periods indicated:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

U.S. Consumer reportable segment
Net sales	$	1,377.0	$	1,311.5	$	1,705.5	$	1,652.4
Adjusted cost of sales (a)	786.7		781.4		1,028.2		1,034.6
Adjusted selling, general and administrative (b)	145.9		133.2		220.6		206.5
Other segment items (c)	7.1		4.8		10.4		9.3
Segment Profit	437.3		392.1		446.3		402.0
Other non-reportable operating segment profit	12.1		9.0		10.2		6.0
Corporate (d)	(44.7)		(35.0)		(70.0)		(69.0)
Intangible asset amortization	(0.7)		(0.7)		(1.3)		(1.4)
Total impairment, restructuring and other (e)	(2.2)		(15.7)		(5.2)		(33.7)
Equity in loss of unconsolidated affiliates	(4.5)		(5.9)		(17.6)		(15.8)
Interest expense	(31.3)		(36.6)		(58.5)		(70.5)
Other non-operating expense, net	(1.1)		(1.2)		(2.3)		(2.5)
Income from continuing operations before income taxes	$	364.9	$	306.0	$	301.6	$	215.1

(a)“Adjusted cost of sales” is defined as cost of sales excluding intangible asset amortization, and does not include activity classified as impairment, restructuring and other.

(b)“Adjusted selling, general and administrative” is defined as selling, general and administrative expenses excluding intangible asset amortization, and does not include activity classified as impairment, restructuring and other.

(c)Other segment items is comprised of activities such as the discount on sales of accounts receivable under the Master Receivables Purchase Agreement, royalty income from the licensing of certain of the Company’s brand names and foreign exchange transaction gains and losses.

(d)The Company incurs costs attributable to corporate functions such as corporate finance, human resources, legal, communications, corporate affairs, corporate travel and corporate executive costs which are considered corporate costs of the Company and not allocated to the segments.

(e)Total impairment, restructuring and other is comprised of the activity classified within the “Cost of sales—impairment, restructuring and other” and “Impairment, restructuring and other” lines in the Condensed Consolidated Statements of Operations. Refer to “NOTE 4. IMPAIRMENT, RESTRUCTURING AND OTHER” for further details.

The following table presents certain other segment disclosures for the periods indicated:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025
Depreciation and amortization:
U.S. Consumer	$	14.3	$	13.6	$	28.3	$	27.2

Share-based compensation:
U.S. Consumer (a)	$	4.4	$	13.1	$	8.9	$	19.7

(a) Includes certain advertising expenses paid for in Common Shares for the three and six months ended March 29, 2025.

The following table presents net sales by product category for the periods indicated:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

U.S. Consumer:
Growing media and mulch	$	561.3	$	596.1	$	672.8	$	689.5
Lawn care	505.5		452.4		615.0		576.7
Controls	150.1		127.7		209.9		192.3
Roundup® marketing agreement	84.9		63.1		108.7		90.8
Other, primarily gardening	75.2		72.2		99.1		103.1
Other:
Growing media	23.5		23.2		36.1		35.8
Lawn care	32.7		28.4		35.8		30.7
Other, primarily gardening and controls	26.3		26.6		36.6		37.4
Total net sales	$	1,459.5	$	1,389.7	$	1,814.0	$	1,756.3

DISCONTINUED OPERATIONS (Tables)

6 Months Ended

Mar. 28, 2026

Discontinued Operations and Disposal Groups [Abstract]

Disposal Groups, Including Discontinued Operations

The following represents the major components of the financial results of the Hawthorne business for each of the periods presented:


	Three Months Ended			Six Months Ended
		March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025
Net sales		$	26.5	$	32.7	$	49.6	$	84.7
Cost of sales		(18.8)		(24.8)		(37.7)		(66.9)
Cost of sales — impairment, restructuring and other		(0.2)		(2.0)		—		(5.7)
Selling, general and administrative		(4.2)		(10.5)		(10.5)		(21.7)
Impairment, restructuring and other		(3.9)		(0.3)		(4.5)		(0.3)
Other income (expense), net		0.1		0.2		(0.1)		—
Loss from discontinued operations before income taxes		(0.5)		(4.7)		(3.2)		(9.9)
Loss on measurement of held for sale assets		(29.6)		—		(134.4)		—
Income tax benefit from discontinued operations		5.4		1.5		35.6		3.2
Loss from discontinued operations, net of tax		$	(24.7)	$	(3.2)	$	(102.0)	$	(6.7)

The following represents the major classes of assets and liabilities that have been classified as held for sale on the Condensed Consolidated Balance Sheets for each of the periods presented:


	March 28, 2026		March 29, 2025		September 30, 2025

Cash and cash equivalents	$	2.9	$	8.2	$	3.8
Accounts receivable, net	23.7		31.5		26.1
Inventories	47.3		63.6		50.1
Prepaid and other current assets	4.1		14.6		4.8
Property, plant and equipment, net	21.1		31.2		24.0
Intangible assets, net	47.3		59.0		49.8
Other assets	16.5		13.6		18.1
Valuation adjustment (allowance) on disposal group	(134.4)		—		—
Total assets held for sale	$	28.5	$	221.7	$	176.7

Accounts payable	$	7.2	$	13.7	$	7.8
Other current liabilities	14.8		23.0		16.5

Other liabilities	7.1		3.8		9.6
Total liabilities held for sale	$	29.1	$	40.5	$	33.9

- Definition

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-SubTopic 10
-Topic 360
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3A
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3A
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483475/205-20-45-11

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-3A

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-4A

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5D
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5D

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A

Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-SubTopic 20
-Topic 205
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-1

Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-3

+ Details

INCOME TAXES	6 Months Ended
INCOME TAXES	Mar. 28, 2026
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 10. INCOME TAXES The effective tax rates related to continuing operations for the six months ended March 28, 2026 and March 29, 2025 were 28.5% and 28.1%, respectively. The effective tax rate used for interim reporting purposes is based on management’s best estimate of factors impacting the effective tax rate for the full fiscal year and includes the impact of discrete items recognized in the period. There can be no assurance that the effective tax rate estimated for interim financial reporting purposes will approximate the effective tax rate determined at fiscal year-end. Scotts Miracle-Gro or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. Subject to the following exceptions, the Company is no longer subject to examination by these tax authorities for fiscal years prior to 2022. There are currently no ongoing audits with respect to the U.S. federal jurisdiction. With respect to foreign jurisdictions, a Canadian audit covering fiscal years 2020 through 2021 and a United Kingdom audit covering fiscal year 2023 are in process. The Company is currently under examination by certain U.S. state and local tax authorities covering various periods from fiscal years 2018 through 2022. In addition to the aforementioned audits, certain other tax deficiency notices and refund claims for previous years remain unresolved. The Company currently anticipates that few of its open and active audits will be resolved within the next twelve months. The Company is unable to make a reasonably reliable estimate as to when or if cash settlements with taxing authorities may occur. Although the outcomes of such examinations and the timing of any payments required upon the conclusion of such examinations are subject to significant uncertainty, the Company does not anticipate that the resolution of these tax matters or any events related thereto will result in a material change to its consolidated financial position, results of operations or cash flows. On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (“OBBBA”). The OBBBA makes permanent key elements of the Tax Cuts and Jobs Act, including 100% bonus depreciation, domestic research cost expensing and the business interest expense limitations. The legislation has multiple effective dates, with certain provisions effective in fiscal year 2025 and others implemented through fiscal year 2027. The Company does not anticipate that these tax law changes will have a material impact on its condensed consolidated financial statements.

- Definition

The entire disclosure for income tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477617/942-740-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478822/944-740-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

+ Details

FAIR VALUE MEASUREMENTS - Rollforward (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Mar. 28, 2026	Mar. 29, 2025
Fair value, inputs, level 3 \| Fair Value, Measurements, Recurring \| Convertible debt investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchases	$ 0.0	$ 0.0	$ 2.0	$ 0.0
Debt Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value at beginning of period	26.6	28.1	24.6	45.8
Total realized / unrealized gains (losses) included in net earnings	0.0	0.0	0.0	(7.0)
Total realized / unrealized gains (losses) included in OCI	(0.4)	0.0	(0.4)	0.0
Exchange	0.0	0.0	0.0	(10.7)
Fair value at end of period	$ 26.2	$ 28.1	$ 26.2	$ 28.1

EQUITY - Narrative (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Jan. 26, 2026	Dec. 19, 2025
Schedule of Equity Method Investments [Line Items]
Share repurchase program, authorized amount				$ 500.0
Number of shares authorized (in shares)			2,750
Cash received from exercise of stock options	$ 3.3	$ 10.0
Options
Schedule of Equity Method Investments [Line Items]
Weighted average fair value (USD per share)	$ 19.33	$ 22.20
Unrecognized pre-tax compensation cost	$ 8.5
Cost not yet recognized, period (years)	1 year 10 months 24 days
Restricted Stock Units (RSUs)
Schedule of Equity Method Investments [Line Items]
Unrecognized pre-tax compensation cost	$ 10.4
Cost not yet recognized, period (years)	1 year 1 month 6 days
Granted (USD per share)	$ 58.84	$ 74.21
Unrecognized pre-tax compensation costs, equity incentive	$ 5.4
Units vested, value	27.1	$ 52.2
Accrued award liability	$ 8.8
Performance Shares
Schedule of Equity Method Investments [Line Items]
Cost not yet recognized, period (years)	2 years 2 months 12 days
Granted (USD per share)	$ 64.22	$ 72.01
Unrecognized pre-tax compensation costs, equity incentive	$ 10.6
Units vested, value		$ 5.7

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Millions, $ in Millions	Mar. 28, 2026	Sep. 30, 2025	Mar. 29, 2025
Statement of Financial Position [Abstract]
Accounts receivable, allowances	$ 19.8	$ 10.5	$ 18.1
Property, plant and equipment, accumulated depreciation	$ 850.6	$ 819.7	$ 800.4
Common shares stated value (USD per share)	$ 0.01	$ 0.01	$ 0.01
Common shares outstanding (shares)	58.2	57.8	57.7
Treasury shares, at cost (shares)	10.0	10.4	10.5

DEBT (Tables)

6 Months Ended

Mar. 28, 2026

Debt Disclosure [Abstract]

Components of Long-Term Debt

The components of debt are as follows:


	March 28, 2026		March 29, 2025		September 30, 2025

Credit Facilities:
Revolving loans	$	251.2	$	345.0	$	—
Term loans	493.8		600.0		500.0
Senior Notes due 2031 – 4.000%	500.0		500.0		500.0
Senior Notes due 2032 – 4.375%	400.0		400.0		400.0
Senior Notes due 2029 – 4.500%	450.0		450.0		450.0
Senior Notes due 2026 – 5.250%	250.0		250.0		250.0


Finance lease obligations	13.5		15.6		14.5
Other	2.3		2.5		5.2
Total debt	2,360.8		2,563.1		2,119.7
Less current portions	279.4		54.6		57.2
Less unamortized debt issuance costs	13.0		15.3		13.3
Long-term debt	$	2,068.4	$	2,493.2	$	2,049.2

Schedule of Interest Rate Swap Agreements

The notional amount, effective date, expiration date and rate of each of the swap agreements outstanding at March 28, 2026 are shown in the table below:


Notional Amount ($)		Effective Date (a)	Expiration Date	Fixed Rate

150		6/7/2023	4/7/2027	3.37	%
50		6/7/2023	4/7/2027	3.34	%
100	(b)	11/20/2023	3/22/2027	4.74	%
150	(b)	9/20/2024	9/20/2029	4.25	%
100		4/8/2027	4/8/2030	3.40	%

(a)The effective date refers to the date on which interest payments are first hedged by the applicable swap agreement.

(b)Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time.

MARKETING AGREEMENT - Net Commission Earned Under Marketing Agreement (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Mar. 28, 2026	Mar. 29, 2025
Marketing Agreement [Line Items]
Contribution expenses	$ (849.0)	$ (842.3)	$ (1,113.5)	$ (1,119.0)
Restated Marketing Agreement
Marketing Agreement [Line Items]
Gross commission	58.1	41.1	66.9	51.3
Contribution expenses	(4.5)	(4.5)	(9.0)	(9.0)
Net commission	53.6	36.6	57.9	42.3
Reimbursements associated with Roundup® marketing agreement	32.5	27.1	51.9	49.1
Total net sales associated with Roundup® marketing agreement	$ 86.1	$ 63.7	$ 109.8	$ 91.4

- Definition

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

+ References + Details

LEASES - Additional Information (Details) - USD ($) $ in Millions	Mar. 28, 2026	Sep. 30, 2025	Mar. 29, 2025
Lessee, Lease, Description [Line Items]
Expected lease liability	$ 317.8	$ 260.1	$ 272.5
Operating Lease, Lease Not yet Commenced
Lessee, Lease, Description [Line Items]
Operating lease, not yet commenced	$ 69.3

INCOME TAXES (Details)	6 Months Ended
INCOME TAXES (Details)	Mar. 28, 2026	Mar. 29, 2025
Income Tax Disclosure [Abstract]
Effective tax rate related to continuing operations	28.50%	28.10%

IMPAIRMENT, RESTRUCTURING AND OTHER (Tables)

6 Months Ended

Mar. 28, 2026

Restructuring and Related Activities [Abstract]

Schedules of Impairment, Restructuring and Other Charges, and Activity Related to Liabilities

The following table details impairment, restructuring and other charges for each of the periods presented:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

Cost of sales—impairment, restructuring and other:

Restructuring and other charges, net	$	—	$	3.4	$	1.3	$	4.2
Right-of-use asset impairments	—		1.9		—		2.5

Operating expenses—impairment, restructuring and other:

Restructuring and other charges, net	2.2		10.4		3.9		20.0
Loss on exchange of convertible debt investment	—		—		—		7.0

Total impairment, restructuring and other charges, net	$	2.2	$	15.7	$	5.2	$	33.7

The following table summarizes the activity related to liabilities associated with restructuring activities during the six months ended March 28, 2026:


Amounts accrued at September 30, 2025	$	18.8
Restructuring charges	0.9

Payments	(9.6)
Amounts accrued at March 28, 2026	$	10.1

DEBT

6 Months Ended

Mar. 28, 2026

Debt Disclosure [Abstract]

DEBT

NOTE 7. DEBT

The components of debt are as follows:


	March 28, 2026		March 29, 2025		September 30, 2025

Credit Facilities:
Revolving loans	$	251.2	$	345.0	$	—
Term loans	493.8		600.0		500.0
Senior Notes due 2031 – 4.000%	500.0		500.0		500.0
Senior Notes due 2032 – 4.375%	400.0		400.0		400.0
Senior Notes due 2029 – 4.500%	450.0		450.0		450.0
Senior Notes due 2026 – 5.250%	250.0		250.0		250.0


Finance lease obligations	13.5		15.6		14.5
Other	2.3		2.5		5.2
Total debt	2,360.8		2,563.1		2,119.7
Less current portions	279.4		54.6		57.2
Less unamortized debt issuance costs	13.0		15.3		13.3
Long-term debt	$	2,068.4	$	2,493.2	$	2,049.2

Credit Facilities

On November 21, 2025, the Company entered into a Seventh Amended and Restated Credit Agreement (the “Seventh A&R Credit Agreement”), providing the Company and certain of its subsidiaries with five-year senior secured loan facilities in the aggregate principal amount of $2,000.0, comprised of a revolving credit facility of $1,500.0 and a term loan in the original principal amount of $500.0. The Seventh A&R Credit Agreement also provides the Company with the right to seek additional committed credit under the agreement in an aggregate amount of up to $500.0 plus an unlimited additional amount, subject to certain specified financial and other conditions. The Seventh A&R Credit Agreement will be available for issuance of letters of credit up to $100.0 and will terminate on November 21, 2030. The terms of the Seventh A&R Credit Agreement include customary representations and warranties, affirmative and negative covenants, financial covenants and events of default.

Borrowings under the Seventh A&R Credit Agreement bear interest at variable rates derived from the prevailing U.S. Prime Rate, Federal Reserve Bank of New York Rate, Secured Overnight Financing Rate, Euro Interbank Offered Rate, Canadian Prime Rate or Canadian Overnight Repo Rate Average (all as defined in the Seventh A&R Credit Agreement), based on the Company’s election, plus a spread that depends on the Company’s quarterly-tested leverage ratio.

At March 28, 2026, the Company had letters of credit outstanding in the aggregate principal amount of $93.2, and had $1,155.6 of borrowing availability under the Seventh A&R Credit Agreement. The weighted average interest rates on average borrowings under the credit facilities, excluding the impact of interest rate swaps, were 6.4% and 7.8% for the six months ended March 28, 2026 and March 29, 2025, respectively.

The Seventh A&R Credit Agreement contains, among other obligations, an affirmative covenant regarding the Company’s leverage ratio determined as of the end of each of its fiscal quarters, calculated as average total indebtedness divided by the Company’s earnings before interest, taxes, depreciation and amortization, as adjusted pursuant to the terms of the Seventh A&R Credit Agreement (“Adjusted EBITDA”). The maximum permitted leverage ratio is 5.00. The Company’s leverage ratio was 3.71 at March 28, 2026. The Seventh A&R Credit Agreement also contains an affirmative covenant regarding the Company’s interest coverage ratio determined as of the end of each of its fiscal quarters, calculated as Adjusted EBITDA divided by interest expense, as described in the Seventh A&R Credit Agreement. The minimum required interest coverage ratio is (i) 3.00 for each of the fiscal quarters within fiscal 2026, (ii) 3.25 for each of the fiscal quarters within fiscal 2027 and (iii) 3.50 for fiscal quarters thereafter. The Company’s interest coverage ratio was 5.62 at March 28, 2026.

The Seventh A&R Credit Agreement allows the Company to make unlimited restricted payments (as defined in the Seventh A&R Credit Agreement), including dividend payments on, and repurchases of, Common Shares, as long as the leverage ratio resulting from the making of such restricted payments is 4.00 or less. Otherwise, the Company is limited to restricted payments in an aggregate amount for each fiscal year not to exceed $225.0.

Senior Notes

On December 15, 2016, Scotts Miracle-Gro issued $250.0 aggregate principal amount of 5.250% Senior Notes with a maturity date of December 15, 2026 (the “5.250% Senior Notes”). The 5.250% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 5.250% Senior Notes have interest payment dates of June 15 and December 15 of each year. At March 28, 2026, the $250.0 aggregate principal amount of the 5.250% Senior Notes is classified in the “Current portion of debt” line in the Condensed Consolidated Balance Sheets as it is payable within one year.

On October 22, 2019, Scotts Miracle-Gro issued $450.0 aggregate principal amount of 4.500% Senior Notes due 2029 (the “4.500% Senior Notes”). The 4.500% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.500% Senior Notes have interest payment dates of April 15 and October 15 of each year.

On March 17, 2021, Scotts Miracle-Gro issued $500.0 aggregate principal amount of 4.000% Senior Notes due 2031 (the “4.000% Senior Notes”). The 4.000% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.000% Senior Notes have interest payment dates of April 1 and October 1 of each year.

On August 13, 2021, Scotts Miracle-Gro issued $400.0 aggregate principal amount of 4.375% Senior Notes due 2032 (the “4.375% Senior Notes”). The 4.375% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.375% Senior Notes have interest payment dates of February 1 and August 1 of each year.

Substantially all of Scotts Miracle-Gro’s directly and indirectly owned domestic subsidiaries serve as guarantors of the 5.250% Senior Notes, the 4.500% Senior Notes, the 4.000% Senior Notes and the 4.375% Senior Notes, (collectively, the “Senior Notes”).

Interest Rate Swap Agreements

The Company enters into interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. Interest payments made between the effective date and expiration date are hedged by the swap agreements. Swap agreements that were hedging interest payments as of March 28, 2026, March 29, 2025 and September 30, 2025 had a maximum total U.S. dollar equivalent notional amount of $450.0. The notional amount, effective date, expiration date and rate of each of the swap agreements outstanding at March 28, 2026 are shown in the table below:


Notional Amount ($)		Effective Date (a)	Expiration Date	Fixed Rate

150		6/7/2023	4/7/2027	3.37	%
50		6/7/2023	4/7/2027	3.34	%
100	(b)	11/20/2023	3/22/2027	4.74	%
150	(b)	9/20/2024	9/20/2029	4.25	%
100		4/8/2027	4/8/2030	3.40	%

(a)The effective date refers to the date on which interest payments are first hedged by the applicable swap agreement.

(b)Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time.

Weighted Average Interest Rate

The weighted average interest rates on the Company’s debt, including the impact of interest rate swaps, were 4.9% and 5.5% for the six months ended March 28, 2026 and March 29, 2025, respectively.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/470/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

+ Details

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Mar. 28, 2026

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

The Scotts Miracle-Gro Company (“Scotts Miracle-Gro”) and its subsidiaries (collectively, with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of products for lawn and garden care and indoor and hydroponic gardening. The Company’s products are primarily sold in North America. The Company’s North America consumer lawn and garden business is highly seasonal, with more than 75% of its annual net sales occurring in the second and third fiscal quarters.

Prior to April 8, 2026, the Company operated the Hawthorne segment, which provided nutrients, lighting and other materials used for indoor and hydroponic gardening. The Company completed the divestitures of its Hawthorne business in North America on April 8, 2026 and its Hawthorne business based in the Netherlands on September 30, 2025. During the three months ended December 27, 2025, the Company determined that the Hawthorne business met the criteria to be classified as held for sale, and classified the related assets and liabilities as held for sale on the Condensed Consolidated Balance Sheets for all periods presented. The Company determined this represents a strategic shift, and therefore, effective in the first quarter of fiscal 2026, the Company classified its results of operations for all periods presented to reflect the Hawthorne business as a discontinued operation. See “NOTE 2. DISCONTINUED OPERATIONS” for further details.

Organization and Basis of Presentation

The Company’s unaudited condensed consolidated financial statements for the three and six months ended March 28, 2026 and March 29, 2025 are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The condensed consolidated financial statements include the accounts of Scotts Miracle-Gro and its consolidated subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company consolidates all majority-owned subsidiaries and variable interest entities where the Company has been determined to be the primary beneficiary. The results of businesses acquired or disposed of are included in the condensed consolidated financial statements from the date of each acquisition or up to the date of disposal, respectively. In the opinion of management, interim results reflect all normal and recurring adjustments and are not necessarily indicative of results for a full year.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted or condensed pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, this Quarterly Report on Form 10-Q for the fiscal quarter ended March 28, 2026 (this “Form 10-Q”) should be read in conjunction with Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2025 (the “2025 Annual Report”), which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.

The Company’s Condensed Consolidated Balance Sheet at September 30, 2025 has been derived from the Company’s audited Consolidated Balance Sheet at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.

On March 14, 2025, the Company sold all of the issued and outstanding shares of capital stock of its formerly wholly-owned subsidiary The Hawthorne Collective, Inc. (“THC”) to Bad Dog Holdings LLC (“BDH”) in exchange for a promissory note with a principal amount of $39.0. BDH was formed to hold and manage the investments held by THC and is owned and controlled by a strategic partner of the Company. At the time of the sale, THC held non-voting exchangeable shares of FLUENT Corp. (formerly Cansortium Inc.) (“FLUENT”) (CSE: FNT.U) (OTCQB: CNTMF), a vertically-integrated, multi-state cannabis company, and other minority non-equity investments, with a total book value of $39.0. BDH granted the Company a call option that enables the Company to reacquire all of the issued and outstanding shares of capital stock of THC in exchange for canceling the principal amount of the promissory note and making an additional payment to BDH equal to 5% of any appreciation in the fair value of THC. The Company may, subject to certain restrictions, exercise the call option in its sole and absolute discretion until the earlier of (i) March 14, 2035 and (ii) the date of the consummation of a merger, change in control or consolidation of BDH or a sale, lease, transfer, exclusive license or other disposition of all or substantially all of the assets of BDH. The Company also granted BDH a put option providing BDH with the right to cause the Company to reacquire all the issued and outstanding shares of capital stock of THC in exchange for canceling the principal amount of the promissory note. The Company has determined that it has a variable interest in BDH and that BDH is a variable interest entity. Additionally, based on its assessment of the characteristics of its variable interest in BDH, including the involvement of its de facto agents, the Company has determined it is the primary beneficiary of BDH and, as a result, is required to consolidate BDH in its condensed consolidated financial statements. As of March 28, 2026, BDH had assets of $24.3 that were recorded in the “Other assets” line in the Condensed Consolidated Balance Sheets as a result of consolidating BDH. BDH also had a $41.0 liability as of March 28, 2026 related to the promissory note due to the Company, which was eliminated in consolidation.

Assets and Liabilities Held for Sale

Assets and liabilities related to a business classified as held for sale are segregated in the Condensed Consolidated Balance Sheets for all periods presented. Upon classification as held for sale, the Company ceases depreciation and amortization and measures the assets (or disposal group) at the lower of carrying amount or fair value less cost to sell. Any resulting loss is recognized in the period in which the held for sale criteria are met. This valuation adjustment (allowance) is adjusted based on subsequent changes in estimates of fair value less cost to sell. During the three months ended December 27, 2025, the Company determined that the Hawthorne business met the criteria to be classified as held for sale, and classified the related assets and liabilities as held for sale on the Condensed Consolidated Balance Sheets for all periods presented.

Accounts Receivable

The Company is party to a Master Receivables Purchase Agreement, which is uncommitted and expires on September 1, 2026, under which the Company may sell up to $750.0 of available and eligible outstanding customer accounts receivable generated by sales to five specified customers. The receivable sales are non-recourse to the Company, other than with respect to (i) repurchase obligations and indemnification obligations for any violations by the Company of its respective representations or obligations as seller or servicer and (ii) certain repurchase and payment obligations arising from any dilution of, or dispute with respect to, any purchased receivables that arise after the sale of such purchased receivables to the purchaser not contemplated in the applicable purchase price of such purchased receivable. The recourse obligations of the Company that may arise from time to time are supported by standby letters of credit of $75.0. Transactions under the Master Receivables Purchase Agreement are accounted for as sales of accounts receivable, and the receivables sold are removed from the Condensed Consolidated Balance Sheets at the time of the sales transaction. Proceeds received from the sales of accounts receivable are classified as operating cash flows and collections of previously sold accounts receivable not yet submitted to the buyer are classified as financing cash flows in the Condensed Consolidated Statements of Cash Flows. The Company records the discount on sales in the “Other expense, net” line in the Condensed Consolidated Statements of Operations. At March 28, 2026, March 29, 2025 and September 30, 2025, net receivables derecognized were $654.1, $598.2 and $163.3, respectively. During the three months ended March 28, 2026 and March 29, 2025, proceeds from the sale of receivables under the Master Receivables Purchase Agreement totaled $813.8 and $748.2, respectively, and the total discount recorded on sales was $8.5 and $7.9, respectively. During the six months ended March 28, 2026 and March 29, 2025, proceeds from the sale of receivables under the Master Receivables Purchase Agreement totaled $1,068.5 and $1,022.2, respectively, and the total discount recorded on sales was $11.4 and $11.2, respectively.

Supplier Finance Program

The Company has an agreement to provide a supplier finance program which facilitates participating suppliers’ ability to finance payment obligations of the Company with a designated third-party financial institution. Participating suppliers may, at their sole discretion, elect to finance payment obligations of the Company prior to their scheduled due dates at a discounted price to the participating financial institution. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under this arrangement. The payment terms that the Company negotiates with its suppliers are consistent, regardless of whether a supplier participates in the program. The Company’s current payment terms with a majority of its suppliers generally range from 30 to 60 days, which the Company deems to be commercially reasonable. The Company’s outstanding payment obligations under its supplier finance program were $42.9, $32.1 and $13.9 at March 28, 2026, March 29, 2025 and September 30, 2025, respectively, and are recorded within accounts payable in the Condensed Consolidated Balance Sheets. The associated payments were $154.7 and $153.1 for the six months ended March 28, 2026 and March 29, 2025, respectively, and are classified as operating activities in the Condensed Consolidated Statements of Cash Flows.

Long-Lived Assets

The Company had non-cash investing activities of $10.8 and $6.2 during the six months ended March 28, 2026 and March 29, 2025, respectively, representing unpaid liabilities to acquire property, plant and equipment.

Statements of Cash Flows

Supplemental cash flow information was as follows:


	Six Months Ended
	March 28, 2026		March 29, 2025

Interest paid	$	58.0	$	68.1

Income taxes paid (refunded), net	4.2		(4.2)

Cash and cash equivalents held by the Hawthorne business of $2.9, $8.2 and $3.8 at March 28, 2026, March 29, 2025 and September 30, 2025, respectively, are classified as held for sale and are not included in cash and cash equivalents in the Condensed Consolidated Balance Sheets.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU primarily requires enhanced disclosures and disaggregation of income tax information by jurisdiction in the annual income tax reconciliation and quantitative and qualitative disclosures regarding income taxes paid. The new disclosure requirements are to be applied prospectively, with the option to apply retrospectively, and will be included in the Company’s Annual Report on Form 10-K for the fiscal year ending September 30, 2026. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

In November 2024, the FASB issued ASU No. 2024-03, “Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” This ASU requires disaggregated disclosures on an annual and interim basis, in the notes to the financial statements, of certain categories of expenses that are included in expense line items on the face of the statement of operations. ASU No. 2024-03 is to be applied prospectively, with the option to apply the standard retrospectively, effective for the Company’s fiscal year ending September 30, 2028, and interim periods within the fiscal year ending September 30, 2029. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures.

In September 2025, the FASB issued ASU No. 2025-06, “Intangibles — Goodwill and Other — Internal-Use Software: Targeted Improvements to the Accounting for Internal-Use Software.” This ASU amends the accounting for and disclosure of software costs. ASU No. 2025-06 is effective for the Company’s fiscal year ending September 30, 2029 and interim periods within that fiscal year, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s consolidated financial statements and disclosures.

DEBT - Components of Long-Term Debt (Details) - USD ($) $ in Millions	Mar. 28, 2026	Sep. 30, 2025	Mar. 29, 2025	Aug. 13, 2021	Mar. 17, 2021	Oct. 22, 2019	Dec. 15, 2016
Debt Instrument [Line Items]
Total debt	$ 2,360.8	$ 2,119.7	$ 2,563.1
Less current portions	279.4	57.2	54.6
Long-term debt	2,068.4	2,049.2	2,493.2
Credit Facilities \| Revolving loans
Debt Instrument [Line Items]
Total debt	251.2	0.0	345.0
Credit Facilities \| Term loans
Debt Instrument [Line Items]
Total debt	$ 493.8	$ 500.0	$ 600.0
Senior Notes \| 4.000% Senior Notes Due 2031
Debt Instrument [Line Items]
Interest rate of debt (percentage)	4.00%	4.00%	4.00%		4.00%
Total debt	$ 500.0	$ 500.0	$ 500.0
Senior Notes \| 4.375% Senior Notes Due 2032
Debt Instrument [Line Items]
Interest rate of debt (percentage)	4.375%	4.375%	4.375%	4.375%
Total debt	$ 400.0	$ 400.0	$ 400.0
Senior Notes \| 4.500% Senior Notes Due 2029
Debt Instrument [Line Items]
Interest rate of debt (percentage)	4.50%	4.50%	4.50%			4.50%
Total debt	$ 450.0	$ 450.0	$ 450.0
Senior Notes \| 5.250% Senior Notes Due 2026
Debt Instrument [Line Items]
Interest rate of debt (percentage)	5.25%	5.25%	5.25%				5.25%
Total debt	$ 250.0	$ 250.0	$ 250.0
Long-term debt
Debt Instrument [Line Items]
Less unamortized debt issuance costs	13.0	13.3	15.3
Other
Debt Instrument [Line Items]
Total debt	2.3	5.2	2.5
Finance Lease Obligations
Debt Instrument [Line Items]
Total debt	$ 13.5	$ 14.5	$ 15.6

DISCONTINUED OPERATIONS - Summary of Major Assets and Liabilities (Details) - Discontinued Operations, Held-for-Sale - USD ($) $ in Millions	Mar. 28, 2026	Sep. 30, 2025	Mar. 29, 2025
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash and cash equivalents	$ 2.9	$ 3.8	$ 8.2
Accounts receivable, net	23.7	26.1	31.5
Inventories	47.3	50.1	63.6
Prepaid and other current assets	4.1	4.8	14.6
Property, plant and equipment, net	21.1	24.0	31.2
Intangible assets, net	47.3	49.8	59.0
Other assets	16.5	18.1	13.6
Valuation adjustment (allowance) on disposal group	(134.4)	0.0	0.0
Total assets held for sale	28.5	176.7	221.7
Accounts payable	7.2	7.8	13.7
Other current liabilities	14.8	16.5	23.0
Other liabilities	7.1	9.6	3.8
Total liabilities held for sale	$ 29.1	$ 33.9	$ 40.5

DEBT - Interest Rate Swap Agreements (Details) - USD ($) $ in Millions	Mar. 28, 2026	Sep. 30, 2025	Mar. 29, 2025
Instrument 1
Derivative [Line Items]
Notional Amount ($)	$ 150.0
Fixed Rate	3.37%
Instrument 2
Derivative [Line Items]
Notional Amount ($)	$ 50.0
Fixed Rate	3.34%
Instrument 3
Derivative [Line Items]
Notional Amount ($)	$ 100.0
Fixed Rate	4.74%
Instrument 4
Derivative [Line Items]
Notional Amount ($)	$ 150.0
Fixed Rate	4.25%
Instrument 5
Derivative [Line Items]
Notional Amount ($)	$ 100.0
Fixed Rate	3.40%
Derivatives designated as hedging instruments \| Interest Rate Swap
Derivative [Line Items]
Notional Amount ($)	$ 450.0	$ 450.0	$ 450.0

MARKETING AGREEMENT - Additional Information (Details) $ in Millions	Aug. 01, 2019 USD ($)
Restated Marketing Agreement
Marketing Agreement [Line Items]
Percentage of program earnings	50.00%
Annual payments	$ 18.0
Third Restated Agreement
Marketing Agreement [Line Items]
Minimum annual EBIT required to avoid reduction of contribution payment	36.0
Minimum EBIT	50.0
Brand decommissioning event payable	375.0
Termination fee payable	$ 175.0
Minimum termination fee payable multiple	4
Minimum termination fee payable threshold	$ 186.4

EQUITY - Summary of Assumptions Used in the Estimation of Fair Value for Awards (Details) - Options	6 Months Ended
	Mar. 28, 2026
Schedule of Equity Method Investments [Line Items]
Expected volatility	38.90%
Risk-free interest rate	3.90%
Expected dividend yield	3.60%
Expected life	6 years 1 month 6 days

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

IMPAIRMENT, RESTRUCTURING AND OTHER

6 Months Ended

Mar. 28, 2026

Restructuring and Related Activities [Abstract]

IMPAIRMENT, RESTRUCTURING AND OTHER

NOTE 4. IMPAIRMENT, RESTRUCTURING AND OTHER

Activity described herein is classified within the “Cost of sales—impairment, restructuring and other” and “Impairment, restructuring and other” lines in the Condensed Consolidated Statements of Operations. The following table details impairment, restructuring and other charges for each of the periods presented:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

Cost of sales—impairment, restructuring and other:

Restructuring and other charges, net	$	—	$	3.4	$	1.3	$	4.2
Right-of-use asset impairments	—		1.9		—		2.5

Operating expenses—impairment, restructuring and other:

Restructuring and other charges, net	2.2		10.4		3.9		20.0
Loss on exchange of convertible debt investment	—		—		—		7.0

Total impairment, restructuring and other charges, net	$	2.2	$	15.7	$	5.2	$	33.7

The following table summarizes the activity related to liabilities associated with restructuring activities during the six months ended March 28, 2026:


Amounts accrued at September 30, 2025	$	18.8
Restructuring charges	0.9

Payments	(9.6)
Amounts accrued at March 28, 2026	$	10.1

As of March 28, 2026, restructuring accruals include $1.1 that is classified as long-term.

Impairment, restructuring and other charges for the three and six months ended March 28, 2026 were not material.

During the three and six months ended March 29, 2025, the Company incurred employee and executive severance charges of $3.0 in its U.S. Consumer segment in the “Cost of sales—impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. During the three and six months ended March 29, 2025, the Company incurred employee and executive severance charges of $3.3 in its U.S. Consumer segment and $2.1 and $11.6, respectively, at Corporate in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations.

During the three and six months ended March 29, 2025, the Company incurred a non-cash loss of $0.0 and $7.0, respectively, in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations related to the exchange of its convertible debt investment in RIV Capital for an investment in FLUENT. Refer to “NOTE 3. INVESTMENT IN UNCONSOLIDATED AFFILIATES” for further details.

During fiscal 2022, the Company began implementing a series of Company-wide organizational changes and initiatives intended to create operational and management-level efficiencies. As part of this restructuring initiative, the Company reduced the size of its supply chain network, reduced staffing levels and implemented other cost-reduction initiatives. During the three and six months ended March 29, 2025, the Company incurred costs of $2.3 and $3.7, respectively, in its U.S. Consumer segment in the “Cost of sales—impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations associated with this restructuring initiative.

DEBT - Weighted Average Interest Rate (Details)	Mar. 28, 2026	Mar. 29, 2025
Debt Disclosure [Abstract]
Weighted average interest rate (percentage)	4.90%	5.50%

EQUITY - Schedule of Stock Option Activity (Details) - Options - USD ($) $ / shares in Units, $ in Millions	6 Months Ended	12 Months Ended
	Mar. 28, 2026	Sep. 30, 2025
Schedule of Equity Method Investments [Line Items]
Awards Outstanding, No of Options (shares)	2,786,576	2,527,668
Awards Outstanding, Wtd. Avg. Exercise Price (USD per share)	$ 66.28	$ 66.43
Awards Outstanding, Wtd. Avg. Remaining Life	7 years 8 months 12 days	7 years 3 months 18 days
Granted (shares)	469,884
Granted (USD per share)	$ 64.22
Exercised (shares)	(42,729)
Exercised (USD per share)	$ 59.45
Forfeited (shares)	(168,247)
Forfeited (USD per share)	$ 64.44
Awards outstanding, aggregate intrinsic value	$ 13.9
Exercisable (shares)	740,432
Weighted average exercise price, exercisable (USD per share)	$ 84.28
Awards Exercisable, Wtd. Avg. Remaining Life	6 years
Exercisable, aggregate intrinsic value	$ 5.5

DEBT - Credit Facilities (Details) $ in Millions	Nov. 21, 2025 USD ($)	Sep. 30, 2028	Sep. 30, 2027	Mar. 28, 2026 USD ($)	Mar. 29, 2025
Debt Instrument [Line Items]
Weighted average interest rate (percentage)				4.90%	5.50%
Revolving Credit Facility
Debt Instrument [Line Items]
Weighted average interest rate (percentage)				6.40%	7.80%
Credit Facilities
Debt Instrument [Line Items]
Available borrowing capacity				$ 1,155.6
Credit Facilities \| Letter of Credit
Debt Instrument [Line Items]
Principal amount				$ 93.2
Senior notes
Debt Instrument [Line Items]
Interest coverage ratio, minimum				3.00
Interest coverage ratio				5.62
Seventh Amended And Restated Senior Secured Credit Agreement \| Credit Facilities
Debt Instrument [Line Items]
Debt, maturity period (years)	5 years
Senior secured credit facilities	$ 2,000.0
Additional committed credit	$ 500.0
Debt instrument, leverage ratio	5.00
Leverage ratio				3.71
Debt Instrument, Covenant, Leverage Ratio, Restricted Payments	4.00
Debt Instrument, Covenant, Annual Restricted Payment Amount, Maximum If Leverage Threshold Exceeded	$ 225.0
Seventh Amended And Restated Senior Secured Credit Agreement \| Credit Facilities \| Forecast
Debt Instrument [Line Items]
Interest coverage ratio, minimum		3.50	3.25
Seventh Amended And Restated Senior Secured Credit Agreement \| Credit Facilities \| Revolving Credit Facility
Debt Instrument [Line Items]
Senior secured credit facilities	1,500.0
Seventh Amended And Restated Senior Secured Credit Agreement \| Credit Facilities \| Term loans
Debt Instrument [Line Items]
Senior secured credit facilities	500.0
Seventh Amended And Restated Senior Secured Credit Agreement \| Credit Facilities \| Letter of Credit
Debt Instrument [Line Items]
Senior secured credit facilities	$ 100.0

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Commodity Contracts (Details)	6 Months Ended		12 Months Ended
	Mar. 28, 2026 T gal	Mar. 29, 2025 T gal	Sep. 30, 2025 T gal
Urea (in tons)
Derivative [Line Items]
Outstanding commodity contracts, mass \| T	0	6,000	49,500
Diesel (in gallons)
Derivative [Line Items]
Outstanding commodity contracts, volume	1,596,000	1,428,000	2,478,000
Heating Oil (in gallons)
Derivative [Line Items]
Outstanding commodity contracts, volume	1,218,000	798,000	1,050,000

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025
OPERATING ACTIVITIES
Net income	$ 113.6	$ 148.0
Adjustments to reconcile net income to net cash used in operating activities:
Impairment, restructuring and other	0.8	16.0
Share-based compensation expense	26.3	38.1
Depreciation	31.0	31.6
Amortization	3.5	6.3
Deferred taxes	(29.8)	39.8
Loss on measurement of held for sale assets	134.4	0.0
Equity in loss of unconsolidated affiliates	17.6	15.8
Changes in assets and liabilities, net of acquisitions and dispositions:
Accounts receivable	(603.9)	(624.3)
Inventories	(150.5)	(189.4)
Prepaid and other current assets	(5.4)	(7.9)
Accounts payable	161.3	153.8
Other current liabilities	132.6	123.6
Other non-current items	20.9	(7.3)
Other, net	(2.8)	(1.3)
Net cash used in operating activities	(150.4)	(257.2)
INVESTING ACTIVITIES
Investments in property, plant and equipment	(38.6)	(37.6)
Other investing, net	(6.8)	2.9
Net cash used in investing activities	(45.4)	(34.7)
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit and term loans	1,179.9	641.9
Repayments under revolving and bank lines of credit and term loans	(938.9)	(320.7)
Financing and issuance fees	(8.7)	0.0
Dividends paid	(77.8)	(78.0)
Purchase of Common Shares	(11.6)	(18.3)
Cash received from exercise of stock options	3.3	10.0
Other financing, net	22.0	3.0
Net cash provided by financing activities	168.2	237.9
Effect of exchange rate changes on cash	0.1	(0.7)
Net decrease in cash and cash equivalents	(27.5)	(54.7)
Less: Net decrease in cash and cash equivalents classified within current assets held for sale	(0.9)	(1.0)
Net decrease in cash and cash equivalents	(26.6)	(53.7)
Cash and cash equivalents at beginning of period	32.8	62.4
Cash and cash equivalents at end of period	$ 6.2	$ 8.7

INVESTMENT IN UNCONSOLIDATED AFFILIATES	6 Months Ended
INVESTMENT IN UNCONSOLIDATED AFFILIATES	Mar. 28, 2026
Equity Method Investments and Joint Ventures [Abstract]
INVESTMENTS IN UNCONSOLIDATED AFFILIATES	NOTE 3. INVESTMENT IN UNCONSOLIDATED AFFILIATES Bonnie Plants The Company holds a 50% equity interest in Bonnie Plants, LLC, a joint venture with Alabama Farmers Cooperative, Inc. (“AFC”) focused on planting, growing, developing, distributing, marketing and selling live plants. The Company’s interest is accounted for using the equity method of accounting, with the Company’s proportionate share of Bonnie Plants, LLC earnings reflected in the Condensed Consolidated Statements of Operations. During the three and six months ended March 28, 2026, the Company recorded equity in loss of unconsolidated affiliates associated with Bonnie Plants, LLC of $4.5 and $15.1, respectively, compared to $5.9 and $15.8 during the three and six months ended March 29, 2025, respectively. FLUENT During the three months ended December 28, 2024, THC exchanged its existing convertible debt investment in RIV Capital Inc. (“RIV Capital”) for an investment in FLUENT. This exchange, a non-cash investing and financing activity, resulted in a loss of $7.0 that was recorded in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations during the three months ended December 28, 2024. As of March 28, 2026, THC holds 153.1 million common shares of FLUENT, which represents approximately 25% of FLUENT’s total outstanding common shares. THC and FLUENT are also parties to an investor rights agreement which allows THC to nominate up to two members to the FLUENT board of directors. This investment was previously accounted for using the equity method of accounting, with THC’s proportionate share of FLUENT earnings subsequent to December 18, 2024 reflected in the Condensed Consolidated Statements of Operations on a one quarter lag. During the three months ended December 27, 2025, the Company’s investment balance in FLUENT was reduced to zero, and the Company discontinued equity method recognition of its proportionate share of FLUENT losses. The Company does not have any contractual obligations or other commitments to fund losses of FLUENT. On April 30, 2026, FLUENT announced that it entered into a definitive arrangement agreement pursuant to which Vireo will acquire all of the issued and outstanding common shares of FLUENT in exchange for common shares of Vireo. Pursuant to the terms of the agreement, each shareholder of FLUENT will receive 0.0705359 of a common share of Vireo in exchange for each FLUENT share held. The closing of the transaction is subject to various conditions, including shareholder, court and regulatory approvals. Refer to “NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES” for further details related to the Company’s sale of THC to BDH on March 14, 2025. BDH is a variable interest entity that is consolidated by the Company.

EQUTY - Schedule of Performance-based Award Activity (Details) - Performance Shares - $ / shares	6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Sep. 30, 2025
Schedule of Equity Method Investments [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	572,558		444,748
Awards outstanding at beginning of period (USD per share)	$ 70.17		$ 75.38
Total share-based awards (shares)	220,519
Granted (USD per share)	$ 64.22	$ 72.01
Vested (shares)	(90,679)
Vested (USD per share)	$ 79.13
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	(2,030)
Forfeited (USD per share)	$ 62.64

EQUITY - Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Mar. 28, 2026	Dec. 27, 2025	Mar. 29, 2025	Dec. 28, 2024	Mar. 28, 2026	Mar. 29, 2025
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	$ (500.6)	$ (357.5)	$ (479.5)	$ (390.6)	$ (357.5)	$ (390.6)
Other comprehensive income (loss) before reclassifications	(0.5)		(0.9)		2.8	0.9
Amounts reclassified from accumulated other comprehensive net income (loss)	3.8		(5.7)		5.4	0.3
Income tax benefit (expense)	(2.1)		2.6		(3.7)	(2.7)
Total other comprehensive income (loss)	1.2	3.5	(4.0)	2.5	4.5	(1.5)
Equity ending balance	(286.5)	(500.6)	(290.1)	(479.5)	(286.5)	(290.1)
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(106.2)	(109.7)	(104.8)	(107.3)	(109.7)	(107.3)
Total other comprehensive income (loss)	1.2	3.5	(4.0)	2.5
Equity ending balance	(105.0)	(106.2)	(108.8)	(104.8)	(105.0)	(108.8)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(9.9)	(12.2)	(27.1)	(21.3)	(12.2)	(21.3)
Other comprehensive income (loss) before reclassifications	(2.0)		1.0		0.3	(4.9)
Amounts reclassified from accumulated other comprehensive net income (loss)	0.0		0.0		0.0	0.0
Income tax benefit (expense)	0.0		0.0		0.0	0.0
Total other comprehensive income (loss)	(2.0)		1.0		0.3	(4.9)
Equity ending balance	(11.9)	(9.9)	(26.1)	(27.1)	(11.9)	(26.1)
Net Unrealized Gain (Loss) On Derivative Instruments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(0.8)	0.3	8.9	4.9	0.3	4.9
Other comprehensive income (loss) before reclassifications	1.9		(1.9)		2.9	5.8
Amounts reclassified from accumulated other comprehensive net income (loss)	0.7		(3.0)		(2.0)	(5.1)
Income tax benefit (expense)	(0.7)		1.3		(0.2)	(0.2)
Total other comprehensive income (loss)	1.9		(3.6)		0.7	0.5
Equity ending balance	1.1	(0.8)	5.3	8.9	1.1	5.3
Net Unrealized Gain (Loss) On Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(17.9)	(17.9)	(14.4)	(14.4)	(17.9)	(14.4)
Other comprehensive income (loss) before reclassifications	(0.4)		0.0		(0.4)	0.0
Amounts reclassified from accumulated other comprehensive net income (loss)	0.0		0.0		0.0	0.0
Income tax benefit (expense)	0.0		0.0		0.0	0.0
Total other comprehensive income (loss)	(0.4)		0.0		(0.4)	0.0
Equity ending balance	(18.2)	(17.9)	(14.4)	(14.4)	(18.2)	(14.4)
Pension and Other Post-Retirement Benefit Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(77.7)	(79.9)	(72.2)	(76.5)	(79.9)	(76.5)
Other comprehensive income (loss) before reclassifications	0.0		0.0		0.0	0.0
Amounts reclassified from accumulated other comprehensive net income (loss)	3.1		(2.7)		7.4	5.4
Income tax benefit (expense)	(1.4)		1.3		(3.5)	(2.5)
Total other comprehensive income (loss)	1.7		(1.4)		3.9	2.9
Equity ending balance	$ (76.0)	$ (77.7)	$ (73.6)	$ (72.2)	$ (76.0)	$ (73.6)

MARKETING AGREEMENT (Tables)

6 Months Ended

Mar. 28, 2026

Marketing Agreement [Abstract]

Schedule of Net Commission and Reimbursements Earned Under Marketing Agreement

The elements of the net commission and reimbursements earned under the Third Restated Agreement and included in the “Net sales” line in the Condensed Consolidated Statements of Operations are as follows:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

Gross commission	$	58.1	$	41.1	$	66.9	$	51.3
Contribution expenses	(4.5)		(4.5)		(9.0)		(9.0)

Net commission	53.6		36.6		57.9		42.3
Reimbursements associated with Roundup® marketing agreement	32.5		27.1		51.9		49.1
Total net sales associated with Roundup® marketing agreement	$	86.1	$	63.7	$	109.8	$	91.4

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Mar. 28, 2026
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 28, 2026 USD ($)	Mar. 29, 2025 USD ($)	Mar. 28, 2026 USD ($)	Mar. 29, 2025 USD ($)	Sep. 30, 2025 USD ($)	Mar. 14, 2025 USD ($)
Significant Accounting Policies [Line Items]
Percentage of annual net sales			75.00%
Liabilities	$ 3,698.5	$ 3,826.8	$ 3,698.5	$ 3,826.8	$ 3,099.5
Total assets	3,412.0	3,536.7	3,412.0	3,536.7	2,742.0
Percentage of appreciation						0.05
Investment in unconsolidated affiliates	36.0	40.6	36.0	40.6	53.6
Other assets	531.9	495.6	531.9	495.6	452.7
Accounts Receivable, Held-for-Sale	750.0		750.0
Net receivables derecognized			654.1	598.2	163.3
Proceeds from sale of receivables	813.8	748.2
Discount On Sale Of Other Receivables	8.5	7.9	11.4	11.2
Proceeds from Sale of Other Receivables			1,068.5	1,022.2
Supplier Finance Program, Obligation	$ 42.9	$ 32.1	42.9	32.1	$ 13.9
Supplier Finance Program, Obligation, Settlement			154.7	153.1
Noncash investing activities for unpaid liabilities incurred			$ 10.8	$ 6.2
Maximum
Significant Accounting Policies [Line Items]
Supplier Finance Program, Payment Timing, Period	60 days		60 days
Minimum
Significant Accounting Policies [Line Items]
Supplier Finance Program, Payment Timing, Period	30 days		30 days
Standby Letters of Credit
Significant Accounting Policies [Line Items]
Senior secured credit facilities	$ 75.0		$ 75.0
Variable Interest Entity, Primary Beneficiary
Significant Accounting Policies [Line Items]
Liabilities	41.0		41.0			$ 39.0
Book value						$ 39.0
Total assets	$ 24.3		$ 24.3

SEGMENT INFORMATION - Other Segment Disclosures (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Mar. 28, 2026	Mar. 29, 2025
Segment Reporting Information [Line Items]
Share-based compensation	$ 18.5	$ 22.0	$ 25.9	$ 38.4
Operating Segments \| U.S. Consumer reportable segment
Segment Reporting Information [Line Items]
Depreciation and amortization:	14.3	13.6	28.3	27.2
Share-based compensation	$ 4.4	$ 13.1	$ 8.9	$ 19.7

LEASES - Supplemental Cash Flow Information and Non-Cash Activity Schedule (Details) - USD ($) $ in Millions	6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025
Lease, Cost [Abstract]
Operating cash flows from operating leases, net	$ 43.4	$ 39.8
Operating cash flows from finance leases	0.3	0.4
Financing cash flows from finance leases	1.0	1.2
Right-of-use assets obtained in exchange for lease obligations, operating leases	90.7	34.3
Right-of-use assets obtained in exchange for lease obligations, finance leases	$ 0.0	$ 0.4

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)

6 Months Ended

Mar. 28, 2026

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Summary of Outstanding Derivative Contracts

The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:

Commodity

March 28,
2026

March 29,
2025

September 30,
2025

Urea

—

6,000 tons

49,500 tons

Diesel

1,596,000 gallons

1,428,000 gallons

2,478,000 gallons

Heating Oil

1,218,000 gallons

798,000 gallons

1,050,000 gallons

DEBT - Senior Notes (Details) - Senior notes - USD ($) $ in Millions	Mar. 17, 2021	Oct. 22, 2019	Dec. 15, 2016	Mar. 28, 2026	Sep. 30, 2025	Mar. 29, 2025	Aug. 13, 2021
Debt Instrument [Line Items]
Interest coverage ratio, minimum				3.00
Interest coverage ratio				5.62
5.250% Senior Notes
Debt Instrument [Line Items]
Interest rate of debt (percentage)			5.25%	5.25%	5.25%	5.25%
Proceeds from issuance of unsecured debt			$ 250.0
4.500% Senior Notes
Debt Instrument [Line Items]
Interest rate of debt (percentage)		4.50%		4.50%	4.50%	4.50%
Proceeds from issuance of unsecured debt		$ 450.0
4.000% Senior Notes
Debt Instrument [Line Items]
Interest rate of debt (percentage)	4.00%			4.00%	4.00%	4.00%
Proceeds from issuance of unsecured debt	$ 500.0
4.375% Senior Notes
Debt Instrument [Line Items]
Interest rate of debt (percentage)				4.375%	4.375%	4.375%	4.375%
Principal amount of debt							$ 400.0

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Mar. 28, 2026
Accounting Policies [Abstract]
Nature of Operations	Nature of Operations The Scotts Miracle-Gro Company (“Scotts Miracle-Gro”) and its subsidiaries (collectively, with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of products for lawn and garden care and indoor and hydroponic gardening. The Company’s products are primarily sold in North America. The Company’s North America consumer lawn and garden business is highly seasonal, with more than 75% of its annual net sales occurring in the second and third fiscal quarters. Prior to April 8, 2026, the Company operated the Hawthorne segment, which provided nutrients, lighting and other materials used for indoor and hydroponic gardening. The Company completed the divestitures of its Hawthorne business in North America on April 8, 2026 and its Hawthorne business based in the Netherlands on September 30, 2025. During the three months ended December 27, 2025, the Company determined that the Hawthorne business met the criteria to be classified as held for sale, and classified the related assets and liabilities as held for sale on the Condensed Consolidated Balance Sheets for all periods presented. The Company determined this represents a strategic shift, and therefore, effective in the first quarter of fiscal 2026, the Company classified its results of operations for all periods presented to reflect the Hawthorne business as a discontinued operation. See “NOTE 2. DISCONTINUED OPERATIONS” for further details.
Organization and Basis of Presentation	Organization and Basis of Presentation The Company’s unaudited condensed consolidated financial statements for the three and six months ended March 28, 2026 and March 29, 2025 are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The condensed consolidated financial statements include the accounts of Scotts Miracle-Gro and its consolidated subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company consolidates all majority-owned subsidiaries and variable interest entities where the Company has been determined to be the primary beneficiary. The results of businesses acquired or disposed of are included in the condensed consolidated financial statements from the date of each acquisition or up to the date of disposal, respectively. In the opinion of management, interim results reflect all normal and recurring adjustments and are not necessarily indicative of results for a full year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted or condensed pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, this Quarterly Report on Form 10-Q for the fiscal quarter ended March 28, 2026 (this “Form 10-Q”) should be read in conjunction with Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2025 (the “2025 Annual Report”), which includes a complete set of footnote disclosures, including the Company’s significant accounting policies. The Company’s Condensed Consolidated Balance Sheet at September 30, 2025 has been derived from the Company’s audited Consolidated Balance Sheet at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements. On March 14, 2025, the Company sold all of the issued and outstanding shares of capital stock of its formerly wholly-owned subsidiary The Hawthorne Collective, Inc. (“THC”) to Bad Dog Holdings LLC (“BDH”) in exchange for a promissory note with a principal amount of $39.0. BDH was formed to hold and manage the investments held by THC and is owned and controlled by a strategic partner of the Company. At the time of the sale, THC held non-voting exchangeable shares of FLUENT Corp. (formerly Cansortium Inc.) (“FLUENT”) (CSE: FNT.U) (OTCQB: CNTMF), a vertically-integrated, multi-state cannabis company, and other minority non-equity investments, with a total book value of $39.0. BDH granted the Company a call option that enables the Company to reacquire all of the issued and outstanding shares of capital stock of THC in exchange for canceling the principal amount of the promissory note and making an additional payment to BDH equal to 5% of any appreciation in the fair value of THC. The Company may, subject to certain restrictions, exercise the call option in its sole and absolute discretion until the earlier of (i) March 14, 2035 and (ii) the date of the consummation of a merger, change in control or consolidation of BDH or a sale, lease, transfer, exclusive license or other disposition of all or substantially all of the assets of BDH. The Company also granted BDH a put option providing BDH with the right to cause the Company to reacquire all the issued and outstanding shares of capital stock of THC in exchange for canceling the principal amount of the promissory note. The Company has determined that it has a variable interest in BDH and that BDH is a variable interest entity. Additionally, based on its assessment of the characteristics of its variable interest in BDH, including the involvement of its de facto agents, the Company has determined it is the primary beneficiary of BDH and, as a result, is required to consolidate BDH in its condensed consolidated financial statements. As of March 28, 2026, BDH had assets of $24.3 that were recorded in the “Other assets” line in the Condensed Consolidated Balance Sheets as a result of consolidating BDH. BDH also had a $41.0 liability as of March 28, 2026 related to the promissory note due to the Company, which was eliminated in consolidation.
Assets and Liabilities Held for Sale	Assets and Liabilities Held for Sale Assets and liabilities related to a business classified as held for sale are segregated in the Condensed Consolidated Balance Sheets for all periods presented. Upon classification as held for sale, the Company ceases depreciation and amortization and measures the assets (or disposal group) at the lower of carrying amount or fair value less cost to sell. Any resulting loss is recognized in the period in which the held for sale criteria are met. This valuation adjustment (allowance) is adjusted based on subsequent changes in estimates of fair value less cost to sell. During the three months ended December 27, 2025, the Company determined that the Hawthorne business met the criteria to be classified as held for sale, and classified the related assets and liabilities as held for sale on the Condensed Consolidated Balance Sheets for all periods presented.
Supplier Finance Program	Supplier Finance Program The Company has an agreement to provide a supplier finance program which facilitates participating suppliers’ ability to finance payment obligations of the Company with a designated third-party financial institution. Participating suppliers may, at their sole discretion, elect to finance payment obligations of the Company prior to their scheduled due dates at a discounted price to the participating financial institution. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under this arrangement. The payment terms that the Company negotiates with its suppliers are consistent, regardless of whether a supplier participates in the program. The Company’s current payment terms with a majority of its suppliers generally range from 30 to 60 days, which the Company deems to be commercially reasonable.
Recently Adopted & Issued Accounting Pronouncements	In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU primarily requires enhanced disclosures and disaggregation of income tax information by jurisdiction in the annual income tax reconciliation and quantitative and qualitative disclosures regarding income taxes paid. The new disclosure requirements are to be applied prospectively, with the option to apply retrospectively, and will be included in the Company’s Annual Report on Form 10-K for the fiscal year ending September 30, 2026. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures. In November 2024, the FASB issued ASU No. 2024-03, “Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” This ASU requires disaggregated disclosures on an annual and interim basis, in the notes to the financial statements, of certain categories of expenses that are included in expense line items on the face of the statement of operations. ASU No. 2024-03 is to be applied prospectively, with the option to apply the standard retrospectively, effective for the Company’s fiscal year ending September 30, 2028, and interim periods within the fiscal year ending September 30, 2029. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s disclosures. In September 2025, the FASB issued ASU No. 2025-06, “Intangibles — Goodwill and Other — Internal-Use Software: Targeted Improvements to the Accounting for Internal-Use Software.” This ASU amends the accounting for and disclosure of software costs. ASU No. 2025-06 is effective for the Company’s fiscal year ending September 30, 2029 and interim periods within that fiscal year, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s consolidated financial statements and disclosures.

EQUITY - Summary of the Changes in Equity (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended				6 Months Ended
	Mar. 28, 2026	Dec. 27, 2025	Mar. 29, 2025	Dec. 28, 2024	Mar. 28, 2026	Mar. 29, 2025
Schedule of Equity Method Investments [Line Items]
Dividends declared (USD per share)	$ 0.66	$ 0.66	$ 0.66	$ 0.66
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity beginning balance	$ (500.6)	$ (357.5)	$ (479.5)	$ (390.6)	$ (357.5)	$ (390.6)
Net income (loss)	238.6	(125.0)	217.5	(69.5)	113.6	148.0
Other comprehensive income (loss)	1.2	3.5	(4.0)	2.5	4.5	(1.5)
Share-based compensation	13.8	24.3	8.7	31.4
Dividends declared	(38.8)	(38.5)	(39.6)	(38.5)
Treasury share purchases	(3.3)	(8.3)	(2.7)	(15.6)
Treasury share issuances	2.6	0.9	9.4	0.8
Equity ending balance	(286.5)	(500.6)	(290.1)	(479.5)	(286.5)	(290.1)
Common Shares and Capital in Excess of Stated Value
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity beginning balance	346.9	351.6	349.1	362.0	351.6	362.0
Share-based compensation	13.8	24.3	8.7	31.4
Treasury share issuances	(14.4)	(29.0)	(14.5)	(44.3)
Equity ending balance	346.3	346.9	343.4	349.1	346.3	343.4
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity beginning balance	131.2	294.7	195.8	303.8	294.7	303.8
Net income (loss)	238.6	(125.0)	217.5	(69.5)
Dividends declared	(38.8)	(38.5)	(39.6)	(38.5)
Equity ending balance	331.0	131.2	373.7	195.8	331.0	373.7
Treasury Stock, Common
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity beginning balance	(872.5)	(894.1)	(919.6)	(949.1)	(894.1)	(949.1)
Treasury share purchases	(3.3)	(8.3)	(2.7)	(15.6)
Treasury share issuances	17.0	29.9	23.9	45.1
Equity ending balance	(858.8)	(872.5)	(898.4)	(919.6)	(858.8)	(898.4)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity beginning balance	(106.2)	(109.7)	(104.8)	(107.3)	(109.7)	(107.3)
Other comprehensive income (loss)	1.2	3.5	(4.0)	2.5
Equity ending balance	$ (105.0)	$ (106.2)	$ (108.8)	$ (104.8)	$ (105.0)	$ (108.8)

SEGMENT INFORMATION

6 Months Ended

Mar. 28, 2026

Segment Reporting [Abstract]

SEGMENT INFORMATION

As a result of the classification of the Hawthorne business as a discontinued operation, the Company’s reportable segments for the three and six months ended March 28, 2026 differ from prior periods. The prior period amounts have been reclassified to reflect the removal of Hawthorne as a reportable segment and from results of continuing operations. The Company has two operating segments: U.S. Consumer and Other; and one reportable segment: U.S. Consumer. Management has chosen to organize the entity primarily around differences in geographic areas. U.S. Consumer consists of the Company’s consumer lawn and garden business in the United States. Other primarily consists of the Company’s consumer lawn and garden business in Canada and does not meet any of the quantitative thresholds requiring separate reportable segment disclosures. This identification of operating segments is consistent with how the segments are managed by the Chief Executive Officer, who has been determined to be the chief operating decision maker (“CODM”) of the Company. The Company is not managed on a consolidated basis. In addition, Corporate consists of general and administrative expenses and certain other income and expense items not allocated to the Company’s operating segments. The accounting policies of the segments are the same as those described in the Company’s summary of significant accounting policies.

The CODM uses Segment Profit (Loss), which is defined as income (loss) from continuing operations before income taxes, amortization, impairment, restructuring and other charges (“Segment Profit (Loss)”), to evaluate segment performance, monitor actual results as compared to plan and inform resource allocation decisions. The Company believes this measure is indicative of performance trends and the overall earnings potential of each segment. Asset information and capital expenditures by segment are not provided to the CODM and they are not utilized for the purposes of assessing performance or allocating resources, and therefore such information has not been presented.

The following table presents net sales by segment and a reconciliation to the Company’s consolidated net sales for the periods indicated:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025


U.S. Consumer reportable segment	$	1,377.0	$	1,311.5	$	1,705.5	$	1,652.4
Other non-reportable operating segment	82.5		78.2		108.5		103.9
Consolidated	$	1,459.5	$	1,389.7	$	1,814.0	$	1,756.3


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

U.S. Consumer reportable segment
Net sales	$	1,377.0	$	1,311.5	$	1,705.5	$	1,652.4
Adjusted cost of sales (a)	786.7		781.4		1,028.2		1,034.6
Adjusted selling, general and administrative (b)	145.9		133.2		220.6		206.5
Other segment items (c)	7.1		4.8		10.4		9.3
Segment Profit	437.3		392.1		446.3		402.0
Other non-reportable operating segment profit	12.1		9.0		10.2		6.0
Corporate (d)	(44.7)		(35.0)		(70.0)		(69.0)
Intangible asset amortization	(0.7)		(0.7)		(1.3)		(1.4)
Total impairment, restructuring and other (e)	(2.2)		(15.7)		(5.2)		(33.7)
Equity in loss of unconsolidated affiliates	(4.5)		(5.9)		(17.6)		(15.8)
Interest expense	(31.3)		(36.6)		(58.5)		(70.5)
Other non-operating expense, net	(1.1)		(1.2)		(2.3)		(2.5)
Income from continuing operations before income taxes	$	364.9	$	306.0	$	301.6	$	215.1

(a)“Adjusted cost of sales” is defined as cost of sales excluding intangible asset amortization, and does not include activity classified as impairment, restructuring and other.

The following table presents certain other segment disclosures for the periods indicated:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025
Depreciation and amortization:
U.S. Consumer	$	14.3	$	13.6	$	28.3	$	27.2

Share-based compensation:
U.S. Consumer (a)	$	4.4	$	13.1	$	8.9	$	19.7

(a) Includes certain advertising expenses paid for in Common Shares for the three and six months ended March 29, 2025.

The following table presents net sales by product category for the periods indicated:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

U.S. Consumer:
Growing media and mulch	$	561.3	$	596.1	$	672.8	$	689.5
Lawn care	505.5		452.4		615.0		576.7
Controls	150.1		127.7		209.9		192.3
Roundup® marketing agreement	84.9		63.1		108.7		90.8
Other, primarily gardening	75.2		72.2		99.1		103.1
Other:
Growing media	23.5		23.2		36.1		35.8
Lawn care	32.7		28.4		35.8		30.7
Other, primarily gardening and controls	26.3		26.6		36.6		37.4
Total net sales	$	1,459.5	$	1,389.7	$	1,814.0	$	1,756.3

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

LEASES - Weighted-Average Remaining Lease Term and Discount Rate Schedule (Details)	Mar. 28, 2026	Sep. 30, 2025	Mar. 29, 2025
Leases [Abstract]
Operating leases, weighted average remaining term (in years)	7 years 8 months 12 days	5 years 2 months 12 days	5 years 3 months 18 days
Finance leases, weighted average remaining term (in years)	7 years 6 months	7 years 9 months 18 days	8 years 1 month 6 days
Operating leases, weighted average discount rate (percent)	7.20%	7.00%	6.70%
Finance leases, weighted average discount rate (percent)	4.60%	4.60%	4.60%

SEGMENT INFORMATION - Net Sales by Geographic Area (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Mar. 28, 2026	Mar. 29, 2025
Segment Reporting Information [Line Items]
Net sales	$ 1,459.5	$ 1,389.7	$ 1,814.0	$ 1,756.3
U.S. Consumer reportable segment
Segment Reporting Information [Line Items]
Net sales	1,377.0	1,311.5	1,705.5	1,652.4
Other non-reportable operating segment
Segment Reporting Information [Line Items]
Net sales	$ 82.5	$ 78.2	$ 108.5	$ 103.9

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-4

+ Details

LEASES

6 Months Ended

Mar. 28, 2026

Leases [Abstract]

LEASES

NOTE 14. LEASES

The Company leases certain property and equipment from third parties under various non-cancelable lease agreements, including industrial, commercial and office properties and equipment that support the management, manufacturing, distribution and research and development of products marketed and sold by the Company. The lease agreements generally require that the Company pay taxes, insurance and maintenance expenses related to the leased assets. At March 28, 2026, the Company had entered into operating leases that were yet to commence with a combined total expected lease liability of $69.3. From time to time, the Company will sublease portions of its facilities, resulting in sublease income. Sublease income and the related cash flows were not material to the condensed consolidated financial statements for the three and six months ended March 28, 2026 and March 29, 2025.

Supplemental balance sheet information related to the Company’s leases was as follows:


	Balance Sheet Location	March 28, 2026		March 29, 2025		September 30, 2025

Operating leases:
Right-of-use assets	Other assets	$	284.4	$	252.5	$	243.9

Current lease liabilities	Other current liabilities	60.9		69.7		67.5
Non-current lease liabilities	Other liabilities	256.9		202.8		192.6
Total operating lease liabilities		$	317.8	$	272.5	$	260.1

Finance leases:
Right-of-use assets	Property, plant and equipment, net	$	10.7	$	12.9	$	11.7

Current lease liabilities	Current portion of debt	2.0		2.1		2.0
Non-current lease liabilities	Long-term debt	11.5		13.5		12.5
Total finance lease liabilities		$	13.5	$	15.6	$	14.5

Components of lease cost were as follows:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

Operating lease cost (a)	$	22.3	$	20.1	$	43.8	$	40.1
Variable lease cost	6.3		6.3		10.9		10.9


Finance lease cost
Amortization of right-of-use assets	0.6		0.6		1.1		1.3
Interest on lease liabilities	0.1		0.2		0.3		0.4
Total finance lease cost	$	0.7	$	0.8	$	1.4	$	1.7

Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows:


	Six Months Ended
		March 28, 2026		March 29, 2025
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases, net		$	43.4	$	39.8
Operating cash flows from finance leases		0.3		0.4
Financing cash flows from finance leases		1.0		1.2

Right-of-use assets obtained in exchange for lease obligations:
Operating leases		$	90.7	$	34.3
Finance leases		—		0.4

Weighted-average remaining lease term and discount rate for the Company’s leases were as follows:


	March 28, 2026		March 29, 2025		September 30, 2025
Weighted-average remaining lease term (in years):
Operating leases	7.7		5.3		5.2
Finance leases	7.5		8.1		7.8

Weighted-average discount rate:
Operating leases	7.2	%	6.7	%	7.0	%
Finance leases	4.6	%	4.6	%	4.6	%

Maturities of lease liabilities by fiscal year for the Company’s leases as of March 28, 2026 were as follows:


Year	Operating Leases		Finance Leases
2026 (remainder of the year)	$	44.4	$	1.3
2027	70.8		2.5
2028	61.8		2.1
2029	49.1		1.7
2030	36.8		1.7
Thereafter	159.4		7.0
Total lease payments	422.3		16.3
Less: Imputed interest	(104.5)		(2.8)
Total lease liabilities	$	317.8	$	13.5

LEASES

NOTE 14. LEASES

Supplemental balance sheet information related to the Company’s leases was as follows:


	Balance Sheet Location	March 28, 2026		March 29, 2025		September 30, 2025

Operating leases:
Right-of-use assets	Other assets	$	284.4	$	252.5	$	243.9

Current lease liabilities	Other current liabilities	60.9		69.7		67.5
Non-current lease liabilities	Other liabilities	256.9		202.8		192.6
Total operating lease liabilities		$	317.8	$	272.5	$	260.1

Finance leases:
Right-of-use assets	Property, plant and equipment, net	$	10.7	$	12.9	$	11.7

Current lease liabilities	Current portion of debt	2.0		2.1		2.0
Non-current lease liabilities	Long-term debt	11.5		13.5		12.5
Total finance lease liabilities		$	13.5	$	15.6	$	14.5

Components of lease cost were as follows:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

Operating lease cost (a)	$	22.3	$	20.1	$	43.8	$	40.1
Variable lease cost	6.3		6.3		10.9		10.9


Finance lease cost
Amortization of right-of-use assets	0.6		0.6		1.1		1.3
Interest on lease liabilities	0.1		0.2		0.3		0.4
Total finance lease cost	$	0.7	$	0.8	$	1.4	$	1.7

Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows:


	Six Months Ended
		March 28, 2026		March 29, 2025
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases, net		$	43.4	$	39.8
Operating cash flows from finance leases		0.3		0.4
Financing cash flows from finance leases		1.0		1.2

Right-of-use assets obtained in exchange for lease obligations:
Operating leases		$	90.7	$	34.3
Finance leases		—		0.4

Weighted-average remaining lease term and discount rate for the Company’s leases were as follows:


	March 28, 2026		March 29, 2025		September 30, 2025
Weighted-average remaining lease term (in years):
Operating leases	7.7		5.3		5.2
Finance leases	7.5		8.1		7.8

Weighted-average discount rate:
Operating leases	7.2	%	6.7	%	7.0	%
Finance leases	4.6	%	4.6	%	4.6	%

Maturities of lease liabilities by fiscal year for the Company’s leases as of March 28, 2026 were as follows:


Year	Operating Leases		Finance Leases
2026 (remainder of the year)	$	44.4	$	1.3
2027	70.8		2.5
2028	61.8		2.1
2029	49.1		1.7
2030	36.8		1.7
Thereafter	159.4		7.0
Total lease payments	422.3		16.3
Less: Imputed interest	(104.5)		(2.8)
Total lease liabilities	$	317.8	$	13.5

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details) - USD ($) $ in Millions	Mar. 28, 2026	Sep. 30, 2025	Mar. 29, 2025
Currency forward contracts \| Not Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount ($)	$ 161.4	$ 100.4	$ 157.3
Interest Rate Swap \| Derivatives designated as hedging instruments
Derivative [Line Items]
Notional Amount ($)	$ 450.0	$ 450.0	$ 450.0

FAIR VALUE MEASUREMENTS (Tables)

6 Months Ended

Mar. 28, 2026

Fair Value Disclosures [Abstract]

Fair Value Measurements, Recurring Basis

The following table summarizes the fair value of the Company’s assets and liabilities for which disclosure of fair value is required:


	Fair Value Hierarchy Level	March 28, 2026				March 29, 2025				September 30, 2025
		Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets
Cash equivalents	Level 1	$	—	$	—	$	5.0	$	5.0	$	25.3	$	25.3




Other
Investment securities in non-qualified retirement plan assets	Level 1	30.2		30.2		30.4		30.4		32.6		32.6


Convertible debt investments	Level 3	26.2		26.2		28.1		28.1		24.6		24.6

Liabilities




Debt instruments
Credit facilities – revolving loans	Level 2	251.2		251.2		345.0		345.0		—		—
Credit facilities – term loans	Level 2	493.8		493.8		600.0		600.0		500.0		500.0
Senior Notes due 2031 – 4.000%	Level 2	500.0		455.6		500.0		440.0		500.0		459.4
Senior Notes due 2032 – 4.375%	Level 2	400.0		366.5		400.0		353.0		400.0		367.0
Senior Notes due 2029 – 4.500%	Level 2	450.0		435.4		450.0		420.8		450.0		437.1
Senior Notes due 2026 – 5.250%	Level 2	250.0		249.1		250.0		247.8		250.0		249.4



Other debt	Level 2	2.3		2.3		2.5		2.5		5.2		5.2

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation

Changes in the balance of Level 3 convertible debt investments carried at fair value are presented below. There were no transfers into or out of Level 3.


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025
Fair value at beginning of period	$	26.6	$	28.1	$	24.6	$	45.8
Purchases	—		—		2.0		—
Total realized / unrealized gains (losses) included in net earnings	—		—		—		(7.0)
Total realized / unrealized gains (losses) included in OCI	(0.4)		—		(0.4)		—
Exchange	—		—		—		(10.7)
Fair value at end of period	$	26.2	$	28.1	$	26.2	$	28.1

- Definition

Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.

+ References + Details

IMPAIRMENT, RESTRUCTURING AND OTHER - Impairment, Restructuring and Other Charges (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Dec. 28, 2024	Mar. 28, 2026	Mar. 29, 2025
Restructuring Cost and Reserve [Line Items]
Impairment, restructuring and other	$ 2.2	$ 10.4		$ 3.9	$ 27.0
Loss on exchange of convertible debt			$ 7.0
Total impairment, restructuring and other charges, net	2.2	15.7		5.2	33.7
Cost of sales—impairment, restructuring and other \| Restructuring and other charges, net
Restructuring Cost and Reserve [Line Items]
Impairment, restructuring and other	0.0	3.4		1.3	4.2
Cost of sales—impairment, restructuring and other \| Right-of-use asset impairments
Restructuring Cost and Reserve [Line Items]
Impairment, restructuring and other	0.0	1.9		0.0	2.5
Operating expenses
Restructuring Cost and Reserve [Line Items]
Loss on exchange of convertible debt		0.0		0.0	7.0
Operating expenses \| Restructuring and other charges, net
Restructuring Cost and Reserve [Line Items]
Impairment, restructuring and other	$ 2.2	$ 10.4		$ 3.9	$ 20.0

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

LEASES - Components of Lease Cost Schedule (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Mar. 28, 2026	Mar. 29, 2025
Leases [Abstract]
Operating lease cost	$ 22.3	$ 20.1	$ 43.8	$ 40.1
Variable lease cost	6.3	6.3	10.9	10.9
Amortization of right-of-use assets	0.6	0.6	1.1	1.3
Interest on lease liabilities	0.1	0.2	0.3	0.4
Total finance lease cost	0.7	0.8	1.4	1.7
Operating lease amortization of ROU assets	$ 16.9	$ 16.0	$ 33.3	$ 32.0

LEASES - Supplemental Balance Sheet Information Schedule (Details) - USD ($) $ in Millions	Mar. 28, 2026	Sep. 30, 2025	Mar. 29, 2025
Leases [Abstract]
Operating lease right-of-use-assets	$ 284.4	$ 243.9	$ 252.5
Operating lease current lease liabilities	60.9	67.5	69.7
Operating lease non-current lease liabilities	256.9	192.6	202.8
Total operating lease liabilities	317.8	260.1	272.5
Finance lease right-of-use assets	10.7	11.7	12.9
Finance lease current lease liabilities	2.0	2.0	2.1
Finance lease non-current lease liabilities	11.5	12.5	13.5
Total finance lease liabilities	$ 13.5	$ 14.5	$ 15.6

CONTINGENCIES	6 Months Ended
CONTINGENCIES	Mar. 28, 2026
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	NOTE 11. CONTINGENCIES Management regularly evaluates the Company’s contingencies, including various judicial and administrative proceedings and claims arising in the ordinary course of business, relating to, among other things, product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance accruals are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, the assessment of contingencies is reasonable and related accruals are adequate, both individually and in the aggregate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows. Regulatory Matters At March 28, 2026, the Company had recorded liabilities of $2.5 for environmental actions, the majority of which are for site remediation. The Company believes that the amounts accrued are adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material. Other The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. The Company has not recorded any accruals in its condensed consolidated financial statements as the likelihood of a loss from these cases is not probable at this time. The Company does not believe a reasonably possible loss would be material to the Company’s financial condition, results of operations or cash flows. In addition, the Company does not believe the ultimate resolution of these cases will have a material adverse effect on the Company’s financial condition, results of operations or cash flows. There can be no assurance that future developments related to pending claims or claims filed in the future, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows. Beginning in June 2024, purported shareholders filed lawsuits in the United States District Court for the Southern District of Ohio on behalf of proposed classes of purchasers of Common Shares. The lawsuits were consolidated by the court as In re The Scotts Miracle-Gro Company Securities Litigation (Case No. 2:24-cv-03132). The amended consolidated complaint was filed on May 9, 2025 on behalf of a proposed class of purchasers of Common Shares between May 5, 2021, and August 1, 2023, and asserts claims under Section 10(b), Rule 10b-5 and Section 20(a) of the Exchange Act against the Company and certain of its current and former officers based on alleged misstatements about the Company’s inventories, sales and business prospects. The action seeks, among other things, unspecified monetary damages, reasonable costs and expenses and equitable/injunctive or other relief as deemed appropriate by the Court. The Company believes that the claims asserted are without merit and intends to vigorously defend the action. On April 22, 2026, the Court granted in part and denied in part the defendants’ motion to dismiss. Beginning in July 2024, purported shareholders filed a series of shareholder derivative lawsuits in state and federal courts in Ohio against certain of the Company’s current and former directors and officers. The lawsuits include allegations that generally mirror those asserted in the securities lawsuits described above and assert claims for breach of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement and waste of corporate assets. The federal lawsuits also assert claims under the Exchange Act. The actions seek a judgment in favor of the Company for unspecified damages, disgorgement, interest and costs and expenses, including attorneys’ and experts’ fees. The Company is involved in other lawsuits and claims which arise in the normal course of business relating to advertising claims, securities matters, employment disputes, product complaints and the enforcement and defense of intellectual property rights. These claims individually and in the aggregate are not expected to have a material effect on the Company’s financial condition, results of operations or cash flows.

- Definition

The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 825
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482804/825-20-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.Y.Q4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480102/450-20-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.Y.Q2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480102/450-20-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/450-20/tableOfContent

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 30
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/450-30/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483049/450-30-50-1

+ Details

Cover Page - shares	6 Months Ended
Cover Page - shares	Mar. 28, 2026	May 01, 2026
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 28, 2026
Document Transition Report	false
Entity File Number	001-11593
Entity Registrant Name	Scotts Miracle-Gro Co
Entity Central Index Key	0000825542
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2026
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Incorporation, State or Country Code	OH
Entity Tax Identification Number	31-1414921
Entity Address, Address Line One	14111 Scottslawn Road,
Entity Address, City or Town	Marysville,
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	43041
City Area Code	937
Local Phone Number	644-0011
Title of 12(b) Security	Common Shares, $0.01 stated value
Trading Symbol	SMG
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		58,181,937

EARNINGS PER COMMON SHARE

6 Months Ended

Mar. 28, 2026

Earnings Per Share [Abstract]

EARNINGS PER COMMON SHARE

NOTE 9. EARNINGS PER COMMON SHARE

The following table presents information necessary to calculate basic and diluted net income (loss) per common share for the periods indicated:


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

Net income from continuing operations	$	263.3	$	220.7	$	215.6	$	154.7


Loss from discontinued operations, net of tax	(24.7)		(3.2)		(102.0)		(6.7)
Net income	$	238.6	$	217.5	$	113.6	$	148.0
Basic net income (loss) per common share:
Continuing operations	$	4.53	$	3.83	$	3.72	$	2.69
Discontinued operations	(0.42)		(0.05)		(1.76)		(0.12)
Basic net income per common share	$	4.11	$	3.78	$	1.96	$	2.57

Weighted-average common shares outstanding during the period	58.1		57.6		58.0		57.5
Diluted net income (loss) per common share:
Continuing operations	$	4.46	$	3.78	$	3.65	$	2.64
Discontinued operations	(0.42)		(0.06)		(1.72)		(0.11)
Diluted net income per common share	$	4.04	$	3.72	$	1.93	$	2.53

Weighted-average common shares outstanding during the period	58.1		57.6		58.0		57.5
Dilutive potential common shares	1.0		0.8		1.0		1.1
Weighted-average common shares outstanding during the period plus dilutive potential common shares	59.1		58.4		59.0		58.6

Antidilutive stock options outstanding	0.6		0.6		0.8		0.4

FAIR VALUE MEASUREMENTS

6 Months Ended

Mar. 28, 2026

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

NOTE 13. FAIR VALUE MEASUREMENTS

The following table summarizes the fair value of the Company’s assets and liabilities for which disclosure of fair value is required:


	Fair Value Hierarchy Level	March 28, 2026				March 29, 2025				September 30, 2025
		Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets
Cash equivalents	Level 1	$	—	$	—	$	5.0	$	5.0	$	25.3	$	25.3




Other
Investment securities in non-qualified retirement plan assets	Level 1	30.2		30.2		30.4		30.4		32.6		32.6


Convertible debt investments	Level 3	26.2		26.2		28.1		28.1		24.6		24.6

Liabilities




Debt instruments
Credit facilities – revolving loans	Level 2	251.2		251.2		345.0		345.0		—		—
Credit facilities – term loans	Level 2	493.8		493.8		600.0		600.0		500.0		500.0
Senior Notes due 2031 – 4.000%	Level 2	500.0		455.6		500.0		440.0		500.0		459.4
Senior Notes due 2032 – 4.375%	Level 2	400.0		366.5		400.0		353.0		400.0		367.0
Senior Notes due 2029 – 4.500%	Level 2	450.0		435.4		450.0		420.8		450.0		437.1
Senior Notes due 2026 – 5.250%	Level 2	250.0		249.1		250.0		247.8		250.0		249.4



Other debt	Level 2	2.3		2.3		2.5		2.5		5.2		5.2

Changes in the balance of Level 3 convertible debt investments carried at fair value are presented below. There were no transfers into or out of Level 3.


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025
Fair value at beginning of period	$	26.6	$	28.1	$	24.6	$	45.8
Purchases	—		—		2.0		—
Total realized / unrealized gains (losses) included in net earnings	—		—		—		(7.0)
Total realized / unrealized gains (losses) included in OCI	(0.4)		—		(0.4)		—
Exchange	—		—		—		(10.7)
Fair value at end of period	$	26.2	$	28.1	$	26.2	$	28.1

On December 18, 2024, THC exchanged its convertible debt investment in RIV Capital for an investment in FLUENT. Refer to “NOTE 3. INVESTMENT IN UNCONSOLIDATED AFFILIATES” for further details.

The amortized cost basis of convertible debt investments was $46.4, $44.4 and $44.4 at March 28, 2026, March 29, 2025 and September 30, 2025, respectively. At March 28, 2026, March 29, 2025 and September 30, 2025, gross unrealized losses on convertible debt investments were $20.2, $16.4 and $19.8, respectively, and there were no gross unrealized gains. These investments have been in a continuous unrealized loss position for greater than 12 months as of March 28, 2026. The allowance for expected credit losses was $1.9 at March 28, 2026, March 29, 2025 and September 30, 2025. At March 28, 2026, the weighted-average period until scheduled maturity of the Company’s convertible debt investments was 3.4 years.

INVENTORIES (Tables)

6 Months Ended

Mar. 28, 2026

Inventory Disclosure [Abstract]

Summary of Inventories

Inventories consisted of the following for each of the periods presented:


	March 28, 2026		March 29, 2025		September 30, 2025

Finished goods	$	430.8	$	408.3	$	246.3
Raw materials	193.1		227.3		217.6
Work-in-process	72.1		74.0		78.8
Total	$	696.0	$	709.6	$	542.7

SEGMENT INFORMATION - Net Sales by Product Category (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Mar. 28, 2026	Mar. 29, 2025
Revenue from External Customer [Line Items]
Net sales	$ 1,459.5	$ 1,389.7	$ 1,814.0	$ 1,756.3
U.S. Consumer reportable segment
Revenue from External Customer [Line Items]
Net sales	1,377.0	1,311.5	1,705.5	1,652.4
U.S. Consumer reportable segment \| Growing media and mulch
Revenue from External Customer [Line Items]
Net sales	561.3	596.1	672.8	689.5
U.S. Consumer reportable segment \| Lawn care
Revenue from External Customer [Line Items]
Net sales	505.5	452.4	615.0	576.7
U.S. Consumer reportable segment \| Controls
Revenue from External Customer [Line Items]
Net sales	150.1	127.7	209.9	192.3
U.S. Consumer reportable segment \| Roundup® marketing agreement
Revenue from External Customer [Line Items]
Net sales	84.9	63.1	108.7	90.8
U.S. Consumer reportable segment \| Other, primarily gardening
Revenue from External Customer [Line Items]
Net sales	75.2	72.2	99.1	103.1
Other non-reportable operating segment
Revenue from External Customer [Line Items]
Net sales	82.5	78.2	108.5	103.9
Other non-reportable operating segment \| Lawn care
Revenue from External Customer [Line Items]
Net sales	32.7	28.4	35.8	30.7
Other non-reportable operating segment \| Growing media
Revenue from External Customer [Line Items]
Net sales	23.5	23.2	36.1	35.8
Other non-reportable operating segment \| Other, primarily gardening and controls
Revenue from External Customer [Line Items]
Net sales	$ 26.3	$ 26.6	$ 36.6	$ 37.4

DISCONTINUED OPERATIONS - Summary of Financial Results (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Mar. 28, 2026	Mar. 29, 2025
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss from discontinued operations, net of tax	$ (24.7)	$ (3.2)	$ (102.0)	$ (6.7)
Discontinued Operations, Held-for-Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net sales	26.5	32.7	49.6	84.7
Cost of sales	(18.8)	(24.8)	(37.7)	(66.9)
Cost of sales — impairment, restructuring and other	(0.2)	(2.0)	0.0	(5.7)
Selling, general and administrative	(4.2)	(10.5)	(10.5)	(21.7)
Impairment, restructuring and other	(3.9)	(0.3)	(4.5)	(0.3)
Other income (expense), net	0.1	0.2	(0.1)	0.0
Loss from discontinued operations before income taxes	(0.5)	(4.7)	(3.2)	(9.9)
Loss on measurement of held for sale assets	(29.6)	0.0	(134.4)	0.0
Income tax benefit from discontinued operations	5.4	1.5	35.6	3.2
Loss from discontinued operations, net of tax	$ (24.7)	$ (3.2)	$ (102.0)	$ (6.7)

IMPAIRMENT, RESTRUCTURING AND OTHER - Activity Related to Liabilities Associated with Restructuring (Details) $ in Millions	6 Months Ended
	Mar. 28, 2026 USD ($)
Restructuring Reserve [Roll Forward]
Amounts accrued for restructuring and other, beginning balance	$ 18.8
Restructuring charges	0.9
Payments	(9.6)
Amounts accrued for restructuring and other, ending balance	$ 10.1

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Mar. 28, 2026	Mar. 29, 2025
Statement of Comprehensive Income [Abstract]
Net income	$ 238.6	$ 217.5	$ 113.6	$ 148.0
Other comprehensive income (loss):
Net foreign currency translation adjustment	(2.0)	1.0	0.3	(4.9)
Net unrealized gain (loss) on derivative instruments, net of tax	1.4	(1.4)	2.2	4.3
Reclassification of net unrealized (gain) loss on derivative instruments to net income, net of tax	0.5	(2.2)	(1.5)	(3.8)
Net unrealized loss on securities, net of tax	(0.4)	0.0	(0.4)	0.0
Pension and other post-retirement benefit adjustments, net of tax	1.7	(1.4)	3.9	2.9
Total other comprehensive income (loss)	1.2	(4.0)	4.5	(1.5)
Comprehensive income	$ 239.8	$ 213.5	$ 118.1	$ 146.5

DISCONTINUED OPERATIONS

6 Months Ended

Mar. 28, 2026

Discontinued Operations and Disposal Groups [Abstract]

DISCONTINUED OPERATIONS

NOTE 2. DISCONTINUED OPERATIONS

The Company completed the divestitures of its Hawthorne business in North America on April 8, 2026 and its Hawthorne business based in the Netherlands on September 30, 2025. During the three months ended December 27, 2025, the Company determined that the Hawthorne business met the criteria to be classified as held for sale, and classified the related assets and liabilities as held for sale on the Condensed Consolidated Balance Sheets for all periods presented. The Company determined this represents a strategic shift, and therefore, effective in the first quarter of fiscal 2026, the Company classified its results of operations for all periods presented to reflect the Hawthorne business as a discontinued operation.

On April 8, 2026, the Company completed the sale of its Hawthorne business in North America to Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) in exchange for 213.0 million common shares of Vireo, which represented approximately 14% of Vireo’s total outstanding common shares as of the closing date, and a warrant with a five year term to acquire 80.0 million additional common shares of Vireo at a strike price of $0.85 per share. The sale proceeds are subject to post-closing adjustments that are expected to be finalized during fiscal 2026. On the closing date, the Hawthorne business held cash and cash equivalents of $35.0 that was transferred to Vireo as part of the sale. Additionally, in connection with the transaction, the Company entered into a contract manufacturing agreement and agreed to provide Vireo with $20.0 of manufacturing services over a two-year period for no cost. Pursuant to an agreement executed on April 8, 2026, the Company transferred the sale consideration received to Good Dog Holdings LLC (“GDH”) in exchange for a promissory note. GDH was formed to hold and manage the investments transferred to it by the Company and is owned and controlled by a strategic partner of the Company. GDH granted the Company a call option that enables the Company to reacquire all of the investments held by GDH in exchange for canceling the principal amount of the promissory note. The Company may, subject to certain restrictions, exercise the call option in its sole and absolute discretion until April 8, 2036. The Company also granted GDH a put option providing GDH with the right to cause the Company to reacquire the investments held by GDH in exchange for canceling the principal amount of the promissory note. The Company has determined that it has a variable interest in GDH and that GDH is a variable interest entity. Additionally, based on its assessment of the characteristics of its variable interest in GDH, including the involvement of its de facto agents, the Company has determined it is the primary beneficiary of GDH and, as a result, will be required to consolidate GDH in its condensed consolidated financial statements.

GDH and Vireo are also parties to an investor rights agreement executed on April 8, 2026 which allows GDH to nominate one member to the Vireo board of directors. Pursuant to this right, Christopher J. Hagedorn, Executive Vice President & Chief of Staff of the Company, has been nominated for election to Vireo’s board of directors.

For the three and six months ended March 28, 2026, the Company incurred pre-tax charges of $29.6 and $134.4, respectively, related to valuation adjustments to recognize the carrying amount of the Hawthorne business at fair value less estimated costs to sell in the “Loss from discontinued operations, net of tax” line on the Condensed Consolidated Statements of Operations.

The following represents the major components of the financial results of the Hawthorne business for each of the periods presented:


	Three Months Ended			Six Months Ended
		March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025
Net sales		$	26.5	$	32.7	$	49.6	$	84.7
Cost of sales		(18.8)		(24.8)		(37.7)		(66.9)
Cost of sales — impairment, restructuring and other		(0.2)		(2.0)		—		(5.7)
Selling, general and administrative		(4.2)		(10.5)		(10.5)		(21.7)
Impairment, restructuring and other		(3.9)		(0.3)		(4.5)		(0.3)
Other income (expense), net		0.1		0.2		(0.1)		—
Loss from discontinued operations before income taxes		(0.5)		(4.7)		(3.2)		(9.9)
Loss on measurement of held for sale assets		(29.6)		—		(134.4)		—
Income tax benefit from discontinued operations		5.4		1.5		35.6		3.2
Loss from discontinued operations, net of tax		$	(24.7)	$	(3.2)	$	(102.0)	$	(6.7)

The following represents the major classes of assets and liabilities that have been classified as held for sale on the Condensed Consolidated Balance Sheets for each of the periods presented:


	March 28, 2026		March 29, 2025		September 30, 2025

Cash and cash equivalents	$	2.9	$	8.2	$	3.8
Accounts receivable, net	23.7		31.5		26.1
Inventories	47.3		63.6		50.1
Prepaid and other current assets	4.1		14.6		4.8
Property, plant and equipment, net	21.1		31.2		24.0
Intangible assets, net	47.3		59.0		49.8
Other assets	16.5		13.6		18.1
Valuation adjustment (allowance) on disposal group	(134.4)		—		—
Total assets held for sale	$	28.5	$	221.7	$	176.7

Accounts payable	$	7.2	$	13.7	$	7.8
Other current liabilities	14.8		23.0		16.5

Other liabilities	7.1		3.8		9.6
Total liabilities held for sale	$	29.1	$	40.5	$	33.9

As of March 28, 2026, the assets and liabilities held for sale are classified as current in the Condensed Consolidated Balance Sheets.

The Condensed Consolidated Statements of Cash Flows do not present the cash flows from discontinued operations separately from cash flows from continuing operations. Cash provided by (used in) operating activities related to discontinued operations totaled $1.3 and $(17.3) for the six months ended March 28, 2026 and March 29, 2025, respectively. Cash provided by (used in) investing activities related to discontinued operations was not material for the six months ended March 28, 2026 and March 29, 2025.

EQUITY - Schedule of Restricted Share-based Award Activity (Details) - Restricted Stock Units (RSUs) - $ / shares	6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Sep. 30, 2025
Schedule of Equity Method Investments [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	435,787		478,924
Awards outstanding at beginning of period (USD per share)	$ 57.84		$ 61.28
Total share-based awards (shares)	417,007
Granted (USD per share)	$ 58.84	$ 74.21
Vested (shares)	(457,117)
Vested (USD per share)	$ 62.38
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	(3,027)
Forfeited (USD per share)	$ 60.49

EQUITY - Total Share-based Compensation (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Mar. 28, 2026	Mar. 29, 2025
Equity [Abstract]
Share-based compensation	$ 18.5	$ 22.0	$ 25.9	$ 38.4
Related tax benefit recognized	$ 1.9	$ 4.1	$ 3.3	$ 6.6

INVENTORIES (Details) - USD ($) $ in Millions	Mar. 28, 2026	Sep. 30, 2025	Mar. 29, 2025
Inventory Disclosure [Abstract]
Finished goods	$ 430.8	$ 246.3	$ 408.3
Raw materials	193.1	217.6	227.3
Work-in-process	72.1	78.8	74.0
Total	$ 696.0	$ 542.7	$ 709.6

SEGMENT INFORMATION (Details)	6 Months Ended
SEGMENT INFORMATION (Details)	Mar. 28, 2026 segment
Segment Reporting [Abstract]
Number of Operating Segments	2
Number of reportable segments	1

MARKETING AGREEMENT

6 Months Ended

Mar. 28, 2026

Marketing Agreement [Abstract]

MARKETING AGREEMENT

NOTE 6. MARKETING AGREEMENT

The Scotts Company LLC is the exclusive agent of Monsanto Company, a subsidiary of Bayer AG (“Monsanto”), for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries. The annual commission payable under the Third Amended and Restated Exclusive Agency and Marketing Agreement (the “Third Restated Agreement”) is equal to 50% of the actual earnings before interest and income taxes of Monsanto’s consumer Roundup® business for each program year in the markets covered by the Third Restated Agreement (“Program EBIT”). The Third Restated Agreement also requires the Company to make annual payments of $18.0 to Monsanto as a contribution against the overall expenses of its consumer Roundup® business, subject to reduction pursuant to the Third Restated Agreement for any program year in which the Program EBIT does not equal or exceed $36.0.

Unless Monsanto terminates the Third Restated Agreement due to an event of default by the Company, termination rights under the Third Restated Agreement include the following:

•The Company may terminate the Third Restated Agreement upon the insolvency or bankruptcy of Monsanto;

•Monsanto may terminate the Third Restated Agreement in the event that Monsanto decides to decommission the permits, licenses and registrations needed for, and the trademarks, trade names, packages, copyrights and designs used in, the sale of the Roundup® products in the lawn and garden market (a “Brand Decommissioning Termination”); and

•Each party may terminate the Third Restated Agreement if Program EBIT falls below $50.0 and, in such case, no termination fee would be payable to either party.

The termination fee structure requires Monsanto to pay a termination fee to the Company in an amount equal to (i) $375.0 upon a Brand Decommissioning Termination, and (ii) the greater of $175.0 or four times an amount equal to the average of the Program EBIT for the three program years before the year of termination, minus $186.4, if Monsanto or its successor terminates the Third Restated Agreement as a result of a Roundup Sale or Change of Control of Monsanto (each, as defined in the Third Restated Agreement).


	Three Months Ended				Six Months Ended
	March 28, 2026		March 29, 2025		March 28, 2026		March 29, 2025

Gross commission	$	58.1	$	41.1	$	66.9	$	51.3
Contribution expenses	(4.5)		(4.5)		(9.0)		(9.0)

Net commission	53.6		36.6		57.9		42.3
Reimbursements associated with Roundup® marketing agreement	32.5		27.1		51.9		49.1
Total net sales associated with Roundup® marketing agreement	$	86.1	$	63.7	$	109.8	$	91.4